Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
Int J Infect Dis
    September 2022
  1. MUADCHIMKAEW M, Siripongboonsitti T, Wongpatcharawarakul S, Boonsankaew C, et al
    Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial).
    Int J Infect Dis. 2022 Sep 27. pii: S1201-9712(22)00531.
    >> Share

  2. ALHINAI Z, Park S, Choe YJ, Michelow IC, et al
    A global epidemiological analysis of COVID-19 vaccine types and clinical outcomes.
    Int J Infect Dis. 2022 Sep 22. pii: S1201-9712(22)00514.
    >> Share

  3. CHOBER D, Czajkowski Z, Aksak-Was B, Dalewska-Kucharczyk K, et al
    Improved survival in ICU in severe COVID-19 associated with amantadine use - retrospective study.
    Int J Infect Dis. 2022 Sep 21. pii: S1201-9712(22)00525.
    >> Share

  4. TAMURA D, Yamagishi H, Morisawa Y, Mato T, et al
    Diagnostic accuracy of a novel severe acute respiratory syndrome coronavirus 2 rapid antigen test and usefulness of specimens collected from the anterior nasal cavity.
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00517.
    >> Share

  5. FENIZIA C, Vanetti C, Rana F, Cappelletti G, et al
    SARS-CoV-2 vertical transmission during the first trimester of pregnancy in asymptomatic women.
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00520.
    >> Share

  6. KUBO M, Kubo K, Kobayashi KI, Komiya N, et al
    Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): a case report and literature review.
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00508.
    >> Share

  7. ANDO M, Satonaga Y, Takaki R, Yabe M, et al
    Acute asthma exacerbation due to SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine [Comirnaty(R)]).
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00518.
    >> Share

  8. VICENTINI C, Bordino V, Cornio AR, Meddis D, et al
    Seroprevalence of infection-induced SARS-CoV-2 antibodies among healthcare users of Northern Italy - results from two serosurveys (October-November 2019 - September-October 2021).
    Int J Infect Dis. 2022 Sep 15. pii: S1201-9712(22)00513.
    >> Share

  9. ROTUNDO S, Vecchio E, Abatino A, Giordano C, et al
    Spike-specific T-cell responses in COVID-19 patients successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2.
    Int J Infect Dis. 2022 Sep 15. pii: S1201-9712(22)00515.
    >> Share

  10. KIM AY, Woo W, Yon DK, Lee SW, et al
    Corrigendum to 'Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis' International Journal of Infectious Diseases, Volume 119, June 2022, Page 130-139.
    Int J Infect Dis. 2022;123:166.
    >> Share

  11. D'ABRAMO A, Vita S, Colavita F, Cimini E, et al
    The first case of meningitis associated to SARS-Coronavirus-2 BA.2 variant infection with persistent viremia.
    Int J Infect Dis. 2022 Sep 12. pii: S1201-9712(22)00510.
    >> Share

  12. ANTONAZZO IC, Fornari C, Rozza D, Conti S, et al
    Azithromycin use and outcomes in COVID-19 patients: an observational real-world study.
    Int J Infect Dis. 2022 Sep 8. pii: S1201-9712(22)00504.
    >> Share

  13. GIUSEPPE S, Guarini R, Vaia F, Maggi F, et al
    Monitoring of SARS-CoV-2 circulation using saliva testing in school children, Rome, Italy.
    Int J Infect Dis. 2022 Sep 8. pii: S1201-9712(22)00502.
    >> Share

  14. ZAYET S, Vuillemenot JB, Josset L, Gendrin V, et al
    Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing.
    Int J Infect Dis. 2022 Sep 7. pii: S1201-9712(22)00501.
    >> Share

  15. CHEN CS, Chang CN, Hu CF, Jian MJ, et al
    Critical pediatric neurological illness associated with COVID-19 (Omicron BA.2.3.7 variant) infection in Taiwan: Immunological assessment and viral genome analysis in tertiary medical center.
    Int J Infect Dis. 2022 Sep 7. pii: S1201-9712(22)00500.
    >> Share

  16. ABROI A, Talas UG, Pauskar M, Shablinskaja A, et al
    SARS-CoV-2 dual infection of Delta and Omicron variants in an immunocompetent host - a case report.
    Int J Infect Dis. 2022 Sep 5. pii: S1201-9712(22)00497.
    >> Share

  17. LI YE, Wang S, Reiter RJ, Ren J, et al
    Clinical Cardiovascular Emergencies and the Cellular Basis of COVID-19 Vaccination: from a Dream to Reality?
    Int J Infect Dis. 2022 Sep 5. pii: S1201-9712(22)00498.
    >> Share

  18. LEE SS, Viboud C, Petersen E
    Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control.
    Int J Infect Dis. 2022;122:1002-1004.
    >> Share

    August 2022
  19. WAITS A, Chen JY, Cheng WH, Yeh JI, et al
    Safety and Immunogenicity of MVC-COV1901 Vaccine in Older Adults: Phase 2 Randomized Dose-Comparison Trial.
    Int J Infect Dis. 2022 Aug 29. pii: S1201-9712(22)00491.
    >> Share

  20. BRUNNER WM, Freilich D, Victory J, Krupa N, et al
    Comparison of Antibody Response Durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 Vaccines in Healthcare Workers.
    Int J Infect Dis. 2022 Aug 28. pii: S1201-9712(22)00492.
    >> Share

  21. ASSERI AA, Assiri M, Alshehri MA, Asseri M, et al
    Acute Encephalopathy in a 6-Year-Old Child with Concurrent Coronavirus Disease-2019 Infection: A Case Report from Saudi Arabia.
    Int J Infect Dis. 2022 Aug 20. pii: S1201-9712(22)00483.
    >> Share

  22. SAINZ-GARCIA A, Toledano P, Muro-Fraguas I, Alvarez-Erviti L, et al
    Mask Disinfection using Atmospheric Pressure Cold Plasma.
    Int J Infect Dis. 2022 Aug 19. pii: S1201-9712(22)00482.
    >> Share

  23. OEHLER RL, Vega VR
    Global Vaccine Inequality Threatens to Unleash the Next COVID-19 Variant.
    Int J Infect Dis. 2022 Aug 18. pii: S1201-9712(22)00480.
    >> Share

  24. GHAFFARZADEGAN N
    Effect of mandating vaccination on COVID-19 cases in colleges and universities.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00477.
    >> Share

  25. VIEL S, Markowicz S, Ait-Medjber L, Ouissa R, et al
    Dedicated team to ambulatory care for patients with COVID-19 requiring oxygen: low rate of hospital readmission.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00452.
    >> Share

  26. YU T, Liu F, Yin H, Yi N, et al
    Comment to the article by Pedro Brotons: Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples, IJID 110 (2021) 363-370.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00478.
    >> Share

  27. SANCHEZ-CONDE M, Vizcarra P, Perez-Garcia JM, Gion M, et al
    Pembrolizumab in combination with tocilizumab in high-risk hospitalized COVID-19 patients (COPERNICO): A randomized proof-of-concept phase II study.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00475.
    >> Share

  28. NAVARATNAM AMD, Shrotri M, Nguyen V, Braithwaite I, et al
    Nucleocapsid and spike antibody responses post virologically confirmed SARS-CoV-2 infection: An observational analysis in the Virus Watch community cohort.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00449.
    >> Share

  29. RAYMENANTS J, Duthoo W, Stakenborg T, Verbruggen B, et al
    Exhaled breath SARS-CoV-2 shedding patterns across variants of concern.
    Int J Infect Dis. 2022 Aug 3. pii: S1201-9712(22)00466.
    >> Share

  30. LIANG Y, Mao X, Kuang M, Zhi J, et al
    IL-6 affects the severity of olfactory disorder: A cross-sectional survey of 148 patients who recovered from Omicron infection using the Sniffin' Sticks test in Tianjin, China.
    Int J Infect Dis. 2022 Aug 2. pii: S1201-9712(22)00468.
    >> Share

  31. ALMADHI M, Alsayyad AS, Conroy R, Atkin S, et al
    EPIDEMIOLOGICAL ASSESSMENT OF SARS-COV-2 REINFECTION.
    Int J Infect Dis. 2022 Aug 2. pii: S1201-9712(22)00470.
    >> Share

    July 2022
  32. DE OLIVEIRA JF, de Avila RE, de Oliveira NR, da Cunha Severino Sampaio N, et al
    Persistent symptoms, quality of life and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil.
    Int J Infect Dis. 2022 Jul 28. pii: S1201-9712(22)00458.
    >> Share

  33. SRECKOVIC M, Marjanovic RR, Jovicic BP, Jankovic S, et al
    MULTISYSTEM INFLAMMATORY SYNDROME IN YOUNG ADULT SUCCESSFULLY TREATED WITH PLASMAPHERESIS, IMMUNOGLOBULINS AND CORTICOSTEROIDS: A CASE REPORT.
    Int J Infect Dis. 2022 Jul 28. pii: S1201-9712(22)00454.
    >> Share

  34. LI T, Song R, Wang J, Zhang J, et al
    Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer.
    Int J Infect Dis. 2022 Jul 26. pii: S1201-9712(22)00446.
    >> Share

  35. DAHAL S, Mamelund SE, Luo R, Sattenspiel L, et al
    Investigating COVID-19 transmission and mortality differences among Indigenous and non-Indigenous populations in Mexico.
    Int J Infect Dis. 2022 Jul 26. pii: S1201-9712(22)00447.
    >> Share

  36. AIELLO A, Coppola A, Vanini V, Petrone L, et al
    Accuracy of QuantiFERON SARS-CoV-2 RUO assay and characterization of the CD4(+) and CD8(+) T-cell-SARS-CoV-2 response: comparison with a homemade IFN-gamma release assay.
    Int J Infect Dis. 2022 Jul 22. pii: S1201-9712(22)00444.
    >> Share

  37. DORIA G, Clemente C, Coelho E, Colaco J, et al
    An isothermal lab-on-phone test for easy molecular diagnostic of SARS-CoV-2 near patient and in less than 1 hour.
    Int J Infect Dis. 2022 Jul 22. pii: S1201-9712(22)00436.
    >> Share

  38. VALLADARES-GARRIDO MJ, Failoc-Rojas VE, Soto-Becerra P, Zena-Nanez S, et al
    Clinical-epidemiological variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00442.
    >> Share

  39. VILLAFUERTE DB, Lavrynenko O, Qazi R, Passeri MF, et al
    Chronic Active Epstein-Barr Exacerbated by COVID-19 Co-Infection.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00439.
    >> Share

  40. AKHMETZHANOV AR, Ponce L, Thompson RN
    Emergence potential of Monkeypox in the Western Pacific Region, July 2022.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00441.
    >> Share

  41. LU J, Zhu J, Zhu J, Duong TQ, et al
    LSTM machine learning of longitudinal clinical data accurately predicts acute kidney injury onset in COVID-19: a two-center study.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00429.
    >> Share

  42. ASSAWAKOSRI S, Kanokudom S, Chansaenroj J, Suntronwong N, et al
    Persistence of immunity against Omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination.
    Int J Infect Dis. 2022 Jul 18. pii: S1201-9712(22)00433.
    >> Share

  43. BAIRD D, Muir A, Logan L, MacLennan M, et al
    Validation of the NeuMoDx SARS-CoV-2 Assay with COPAN eNAT(R) and E&O Viral PCR Sample Solution (VPSS) collection media types in comparison with other validated SARS-CoV-2 RNA assays.
    Int J Infect Dis. 2022 Jul 15. pii: S1201-9712(22)00418.
    >> Share

  44. BHATNAGAR T, Chaudhuri S, Ponnaiah M, Yadav PD, et al
    Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: A multi-centric hospital-based case-control study.
    Int J Infect Dis. 2022 Jul 14. pii: S1201-9712(22)00427.
    >> Share

  45. YIN Q, Li Y, Pan H, Hui T, et al
    Atypical pneumonia caused by Chlamydia Psittaci during the COVID-19 pandemic.
    Int J Infect Dis. 2022 Jul 13. pii: S1201-9712(22)00422.
    >> Share

  46. VOOR IN 'T HOLT AF, Haanappel CP, Rahamat-Langendoen J, Molenkamp R, et al
    Admissions to a large tertiary care hospital and Omicron BA.1 and BA.2 SARS-CoV-2 PCR positivity: primary, contributing, or incidental COVID-19.
    Int J Infect Dis. 2022 Jul 13. pii: S1201-9712(22)00424.
    >> Share

  47. MAAMARI KA, Busaidi IA, Kindi MA, Zadjali F, et al
    Short and long-term immune changes in different severity groups of COVID-19 disease.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00421.
    >> Share

  48. ALOTAIBY M, Krissaane I, Seraihi AA, Alshenaifi J, et al
    SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00420.
    >> Share

  49. JUANOLA-FALGARONA M, Penarrubia L, Jimenez-Guzman S, Porco R, et al
    Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using the QIAstat-Dx(R) Respiratory SARS-CoV-2 Panel.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00419.
    >> Share

  50. TOCZYLOWSKI K, Lasecka-Zadrozna J, Palyga-Bysiecka I, Ludwikowska KM, et al
    Use of broad-spectrum antibiotics in children diagnosed with multisystem inflammatory syndrome temporarily associated with SARS-CoV-2 infection in Poland: the MOIS-CoR study.
    Int J Infect Dis. 2022 Jul 10. pii: S1201-9712(22)00416.
    >> Share

  51. DASTENAE ZH, Bahadori A, Dehghani M, Asadi-Samani M, et al
    Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: A randomized clinical trial.
    Int J Infect Dis. 2022 Jul 8. pii: S1201-9712(22)00413.
    >> Share

  52. PETERSEN MS, Kongsstovu SI, Eliasen EH, Larsen S, et al
    Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00405.
    >> Share

  53. NATH H, Mallick A, Roy S, Kayal T, et al
    COVID-19 serum can be cross-reactive and neutralizing against Dengue virus (DV) as observed by DV neutralization test.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00408.
    >> Share

  54. BIBER A, Harmelin G, Lev D, Ram L, et al
    The effect of ivermectin on the viral load and culture viability in early treatment of non-hospitalized patients with mild COVID-19 - A double-blind, randomized placebo-controlled trial.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00399.
    >> Share

  55. FUKUSHIMA T, Chubachi S, Namkoong H, Otake S, et al
    U-shaped association between abnormal serum uric acid levels and COVID-19 severity: Reports from the Japan COVID-19 Task Force.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00409.
    >> Share

  56. MURUGESAN M, Venkatesan P, Kumar S, Thangavelu P, et al
    Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS).
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00402.
    >> Share

  57. RICCIARDI A, Zelini P, Cassaniti I, Avanzini MA, et al
    Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: Prolonged protection from SARS-CoV-2 in newborns and older children.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00392.
    >> Share

  58. TOBBACK E, Degroote S, Buysse S, Delesie L, et al
    Efficacy and safety of camostat mesylate in early Covid-19 disease in an ambulatory setting: A randomized placebo-controlled phase II trial.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00388.
    >> Share

  59. MALINOWSKA J, Malecka-Gieldowska M, Bankowska D, Borecka K, et al
    Hypermagnesemia and hyperphosphatemia are highly prevalent in COVID-19 patients and increase the risk of death.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00394.
    >> Share

  60. SALEH T, Kerin T, Fuller T, Paiola S, et al
    Clinical and epidemiological characteristics of SARS-CoV-2 Infection in Los Angeles County youth during the first year of the pandemic.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00374.
    >> Share

  61. LARSEN CS
    Assessing the proportion of the Danish population at risk of clinically significant drug-drug interactions with new oral antivirals for early treatment of COVID-19.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00391.
    >> Share

  62. DESWAL V, Phogat R, Sharma P, Kataria S, et al
    Is single dose of ChAdOx1 nCoV-19 vaccine (AZD1222) enough for persons with prior SARS-CoV-2 infection or baseline seropositive status?
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00384.
    >> Share

  63. DING L, Chen Y, Su N, Xu X, et al
    Comparison of acute respiratory distress syndrome in patients with COVID-19 and influenza A (H7N9) virus infection.
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00387.
    >> Share

  64. KOH K, Tang KC, Axhausen K, Loo BP, et al
    A metropolitan-scale, three-dimensional agent-based model to assess the effectiveness of the COVID-19 Omicron wave interventions in a hyperdense city: a case study of Hong Kong.
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00376.
    >> Share

  65. XIONG L, Li Q, Cao X, Xiong H, et al
    Recovery of functional fitness, lung function and immune function in health care workers with non-severe and severe COVID-19 at 13 months after discharge from the hospital: a prospective cohort study.
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00386.
    >> Share

  66. CHEN NY, Liu ZH, Kao SW, Lin HS, et al
    Changes in Interferon-Gamma Release Assay Readout after COVID-19 Vaccination: A Prospective Cohort Study.
    Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00382.
    >> Share

  67. ORONSKY B, Larson C, Caroen S, Hedjran F, et al
    Nucleocapsid as a Next Generation COVID-19 Vaccine Candidate.
    Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00379.
    >> Share

  68. ISA F, Forleo-Neto E, Meyer J, Zheng W, et al
    Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
    Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00380.
    >> Share

    June 2022
  69. FARIDL M, Mellyani K, Khoirunnisa K, Septiani P, et al
    RNA-seq analysis of nasopharyngeal swabs from asymptomatic and mildly symptomatic COVID-19 patients.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00368.
    >> Share

  70. DOS SANTOS PG, Vieira HCVS, Wietholter V, Gallina JP, et al
    When to test for COVID-19 using RT-PCR: a systematic review.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00370.
    >> Share

  71. SBERNA G, Fabeni L, Berno G, Carletti F, et al
    Rapid and qualitative identification of SARS-CoV-2 mutations associated with Variants Of Concern (VOC) using a multiplex RT-PCR assay coupled with melting analysis.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00367.
    >> Share

  72. HIROTSU Y, Maejima M, Shibusawa M, Natori Y, et al
    Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00373.
    >> Share

  73. FINSTERER J, Scorza FA
    Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination: COVID-19 associated abdominal epilepsy.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00372.
    >> Share

  74. KAMURA Y, Matsue K
    Severe rhabdomyolysis and SARS-CoV-2 vaccination: A reply to the letter by Dr Josef Finsterer.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00366.
    >> Share

  75. PETERSEN MS, Kristiansen MF, Hanusson KD, Foldbo BM, et al
    Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months follow up.
    Int J Infect Dis. 2022 Jun 23. pii: S1201-9712(22)00364.
    >> Share

  76. RUTER J, Pallerla SR, Meyer CG, Casadei N, et al
    Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19.
    Int J Infect Dis. 2022 Jun 23. pii: S1201-9712(22)00365.
    >> Share

  77. KSHATRI JS, Giri S, Bhattacharya D, Palo SK, et al
    Analysis of the COVID-19 testing parameters and progression of the pandemic at the district level- findings from the ICMR- Hundred Million Test (HMT) database during the first wave in India.
    Int J Infect Dis. 2022 Jun 22. pii: S1201-9712(22)00361.
    >> Share

  78. ROVIDA F, Esposito GL, Rissone M, Novelli V, et al
    Characteristics and outcome of vaccinated and non-vaccinated patients hospitalized in a single Italian HUB for COVID-19 during the Delta and Omicron waves in Northern Italy.
    Int J Infect Dis. 2022 Jun 21. pii: S1201-9712(22)00362.
    >> Share

  79. RIZZO R, Bortolotti D, Morandi L, Rizzo S, et al
    Humoral and adaptive immune responses to SARS-CoV-2 vaccine.
    Int J Infect Dis. 2022 Jun 21. pii: S1201-9712(22)00355.
    >> Share

  80. QUARANTA EG, Fusaro A, Giussani E, D'Amico V, et al
    SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.
    Int J Infect Dis. 2022 Jun 17. pii: S1201-9712(22)00359.
    >> Share

  81. STAMBOULI N, Driss A, Gargouri F, Bahrini K, et al
    COVID-19 prophylaxis with Doxycycline and Zinc in Health Care Workers: A prospective randomized double-blind clinical trial.
    Int J Infect Dis. 2022 Jun 17. pii: S1201-9712(22)00349.
    >> Share

  82. QIN J, Wang G, Han D
    Benefits of plasma exchange on mortality in patients with COVID-19: a systematic review and meta-analysis.
    Int J Infect Dis. 2022 Jun 13. pii: S1201-9712(22)00348.
    >> Share

  83. KOLLER JE, Villinger K, Lages NC, Absetz P, et al
    Individual and collective protective responses during the early phase of the COVID-19 pandemic in 10 different countries: Results from the EUCLID online-survey.
    Int J Infect Dis. 2022 Jun 13. pii: S1201-9712(22)00347.
    >> Share

  84. CLARO F, Silva D, Bogado JAP, Rangel HR, et al
    Lasting SARS-CoV-2 specific IgG Antibody response in health care workers from Venezuela, 6 months after vaccination with Sputnik V.
    Int J Infect Dis. 2022 Jun 8. pii: S1201-9712(22)00341.
    >> Share

  85. TARNAS MC, Desai AN, Parker DM, Almhawish N, et al
    Syndromic surveillance of respiratory infections during protracted conflict: experiences from northern Syria 2016-2021.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00336.
    >> Share

  86. SASANAMI M, Kayano T, Nishiura H
    Monitoring the COVID-19 immune landscape in Japan.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00338.
    >> Share

  87. MANNATHOKO N, Mospele M, Gross R, Smith RM, et al
    Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) and Carbapenem-Resistant Enterobacterales (CRE) in Healthcare and Community Settings in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00337.
    >> Share

  88. KHONGYOT T, Moriyasu T
    Invasive Pneumococcal Disease diminish during the coronavirus disease 2019 in Japan between 2019 and 2022.
    Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00333.
    >> Share

  89. HERNANDEZ PORTO M, Garcia S, Delgado T, Rodriguez Y, et al
    Humoral response to SARS-COV-2 after vaccination and C in dialyzed patients.
    Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00335.
    >> Share

  90. DIVINO F, Alaimo Di Loro P, Farcomeni A, Jona-Lasinio G, et al
    Decreased severity of the Omicron variant of concern: further evidence from Italy.
    Int J Infect Dis. 2022;119:21-23.
    >> Share

    May 2022
  91. LAI X, Deng S, Hu L, Chen R, et al
    J-shaped associations and joint effects of fasting glucose with inflammation and cytokines on COVID-19 mortality.
    Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00324.
    >> Share

  92. BORDI L, Sberna G, Piscioneri CN, Cocchiara RA, et al
    Longitudinal dynamics of SARS-CoV2 anti-Receptor Binding Domain IgG antibodies in a wide population of health care workers after BNT162b2 vaccination.
    Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00325.
    >> Share

  93. BACHELARD A, Sautereau A, Digumber M, Isernia V, et al
    Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1.
    Int J Infect Dis. 2022 May 29. pii: S1201-9712(22)00320.
    >> Share

  94. JIN T, Chen X, Nishio M, Zhuang L, et al
    Interventions to prevent surface transmission of an infectious virus based on real human touch behavior: A case study of the norovirus.
    Int J Infect Dis. 2022 May 29. pii: S1201-9712(22)00311.
    >> Share

  95. ALBERTO-ORLANDO S, Calderon JL, Leon-Sosa A, Patino L, et al
    SARS-CoV-2 transmission from infected owner to household dogs and cats is associated to food sharing.
    Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00313.
    >> Share

  96. TEGETHOFF SA, Danziger G, Kuhn D, Kimmer C, et al
    TRAIL, IP-10, and CRP in predicting the progression of SARS-CoV-2 infection: A prospective, cohort study.
    Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00315.
    >> Share

  97. ALI M, Bonna AS, Sarkar AS, Islam MA, et al
    SARS-CoV-2 infection is associated with low back pain: Findings from a community based case-control study.
    Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00312.
    >> Share

  98. WAWINA-BOKALANGA T, Logist AS, Sinnesael R, Van Holm B, et al
    Genomic evidence of co-identification with Omicron and Delta SARS-CoV-2 variants: A report of two cases.
    Int J Infect Dis. 2022 May 20. pii: S1201-9712(22)00304.
    >> Share

  99. KORAYEM GB, Aljuhani O, Altebainawi AF, Shaya AIA, et al
    The Safety and Efficacy of Tocilizumab in Older Adult Critically Ill Patients with Coronavirus Disease 2019 (COVID-19): A Multi-center, Cohort Study.
    Int J Infect Dis. 2022 May 20. pii: S1201-9712(22)00302.
    >> Share

  100. MATTIUZZI C, Lippi G
    Real-world effectiveness of COVID-19 vaccination among children in Italy.
    Int J Infect Dis. 2022 May 19. pii: S1201-9712(22)00309.
    >> Share

  101. NTAGEREKA PB, Oyola SO, Baenyi SP, Rono GK, et al
    Whole-Genome Sequencing of SARS-CoV-2 Reveals Diverse Mutations in Circulating Alpha and Delta Variants during the First, Second and Third Waves of Covid-19 in South Kivu, East of the Democratic Republic of Congo.
    Int J Infect Dis. 2022 May 19. pii: S1201-9712(22)00307.
    >> Share

  102. KUDHAIL K, Thompson J, Mathews V, Morrison B, et al
    Randomised controlled trials in COVID-19 patients: a systematic review and critical appraisal.
    Int J Infect Dis. 2022 May 18. pii: S1201-9712(22)00299.
    >> Share

  103. KIRSCH F, Lindemann AK, Geppert J, Borzekowski D, et al
    Personal Protective Measures During the Coronavirus Pandemic in Germany.
    Int J Infect Dis. 2022 May 18. pii: S1201-9712(22)00297.
    >> Share

  104. EYU P, Elyanu P, Ario AR, Ntono V, et al
    Investigation of Possible Preventable Causes of COVID-19 Deaths in the Kampala Metropolitan Area, Uganda, 2020-2021.
    Int J Infect Dis. 2022 May 17. pii: S1201-9712(22)00296.
    >> Share

  105. GUPTA S, Gupta T, Gupt N
    Global Respiratory Virus Surveillance: Strengths, Gaps and Way Forward.
    Int J Infect Dis. 2022 May 15. pii: S1201-9712(22)00294.
    >> Share

  106. XUE L, Jing S, Zhang K, Milne R, et al
    Infectivity versus fatality of SARS-CoV-2 mutations and influenza.
    Int J Infect Dis. 2022 May 15. pii: S1201-9712(22)00295.
    >> Share

  107. OKOTURO E, Amure M
    SARS-CoV-2 saliva testing using reverse transcriptase - polymerase chain reaction (RT-PCR): A Systematic Review.
    Int J Infect Dis. 2022 May 13. pii: S1201-9712(22)00272.
    >> Share

  108. NISHIURA H, Jung SM, Hayashi K
    High population burden of Omicron variant (B.1.1.529) is associated with the emergence of severe hepatitis of unknown etiology in children.
    Int J Infect Dis. 2022 May 13. pii: S1201-9712(22)00290.
    >> Share

  109. MARCO R, Angelo DV
    Commentary to the paper: Association of smoking and severity of covid-19 infection among 5889 patients in malaysia: a multi-centre observational study, by Ismail N, Hassan N, Hamid MHNA, Yusoff UN, Khamal NR, Omar MA, et al. published in Int J Infect
    Int J Infect Dis. 2022 May 12. pii: S1201-9712(22)00284.
    >> Share

  110. INGHELS M, Kane R, Lall P, Nelson D, et al
    Ethnicity and risk of SARS-CoV-2 infection among the healthcare workforce: Results of a retrospective cohort study in rural United Kingdom.
    Int J Infect Dis. 2022 May 12. pii: S1201-9712(22)00281.
    >> Share

  111. YILDIZ Y, Ozger HS, Senol E, Karakus R, et al
    Evaluation of long term antibody kinetics in healthcare workers (HCWs) vaccinated with inactivated COVID-19 vero cell vaccine (CoronaVac), a propensity score matched observational study: Antibody kinetics in HCWs after CoronaVac vaccination.
    Int J Infect Dis. 2022 May 11. pii: S1201-9712(22)00271.
    >> Share

  112. OLIVEIRA-SILVA J, Reis T, Lopes C, Batista-Silva R, et al
    Long term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers.
    Int J Infect Dis. 2022 May 11. pii: S1201-9712(22)00289.
    >> Share

  113. CHEN F, Tian Y, Zhang L, Shi Y, et al
    The Role of Children in Household Transmission of COVID-19: A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2022 May 10. pii: S1201-9712(22)00283.
    >> Share

  114. ICHIKAWA T, Torii S, Suzuki H, Takada A, et al
    Mutations in the non-structural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in COVID-19 patients.
    Int J Infect Dis. 2022 May 10. pii: S1201-9712(22)00275.
    >> Share

  115. BALUSHI AA, Ajmi AA, Sinani QA, Menon V, et al
    COVID-19 Associated Mucormycosis: Opportunistic Fugal Infection. A case series and review.
    Int J Infect Dis. 2022 May 6. pii: S1201-9712(22)00267.
    >> Share

  116. COLANERI M, Amarasinghe N, Rezzonico L, Pieri TC, et al
    Early Remdesivir to prevent severe COVID-19 in solid organ transplant recipients: a real-life study from Northern Italy.
    Int J Infect Dis. 2022 May 6. pii: S1201-9712(22)00263.
    >> Share

    April 2022
  117. KAMEGAI K, Iwamoto N, Togano T, Maeda K, et al
    A Fatal Breakthrough Coronavirus Disease 2019 Case Following Bendamustine-Rituximab Therapy.
    Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00258.
    >> Share

  118. YOSHIMURA Y, Sasaki H, Miyata N, Miyazaki K, et al
    An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination.
    Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00257.
    >> Share

  119. HUSIN M, Tok PSK, Suah JL, Thevananthan T, et al
    Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia.
    Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00251.
    >> Share

  120. BHAKTA S, Sanghavi DK, Johnson PW, Kunze KL, et al
    Clinical and Laboratory Profiles of SARS-CoV-2 Delta Variant Compared to Pre-Delta Variants.
    Int J Infect Dis. 2022 Apr 26. pii: S1201-9712(22)00252.
    >> Share

  121. PAROLINA L, Pshenichnaya N, Vasilyeva I, Lizinfed I, et al
    Clinical characteristics of COVID-19 in TB patients and factors associated with the disease severity.
    Int J Infect Dis. 2022 Apr 25. pii: S1201-9712(22)00232.
    >> Share

  122. LI J, Liu B, Tang X, Wu Z, et al
    Development of a smartphone based quantum-dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies.
    Int J Infect Dis. 2022 Apr 25. pii: S1201-9712(22)00235.
    >> Share

  123. MURILLO-ZAMORA E, Trujillo X, Huerta M, Rios-Silva M, et al
    COVID-19 vaccines provide better protection against related pneumonia than previous symptomatic infection.
    Int J Infect Dis. 2022 Apr 24. pii: S1201-9712(22)00245.
    >> Share

  124. XIA Y, Ma H, Buckeridge DL, Brisson M, et al
    Mortality trends and lengths of stay among hospitalized COVID-19 patients in Ontario and Quebec (Canada): a population-based cohort study of the first three epidemic waves.
    Int J Infect Dis. 2022 Apr 24. pii: S1201-9712(22)00246.
    >> Share

  125. STEIN M, Cohen H, Nemet I, Atari N, et al
    Human Metapneumovirus prevalence during 2019-2021 in Israel is influence by the COVID-19 pandemic.
    Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00241.
    >> Share

  126. TORRES JP, Saure D, Basso LJ, Zuniga M, et al
    SARS-COV-2 IgG positivity in vaccinated and non-vaccinated Chilean children: a national cross-sectional study in Schools.
    Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00238.
    >> Share

  127. LAI MY, Bukhari FDM, Zulkefli NZ, Ismail I, et al
    Colorimetric detection of SARS-CoV-2 by uracil-DNA glycosylase (UDG) reverse transcription loop-mediated isothermal amplification (RT-LAMP).
    Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00239.
    >> Share

  128. MAMETJA S, Dessie ZG, Matoti L, Semenya M, et al
    Clinical Management of COVID-19 in Hospitals and the Community: A Snapshot from a Medical Insurance Database in South Africa.
    Int J Infect Dis. 2022 Apr 22. pii: S1201-9712(22)00231.
    >> Share

  129. HUNG DT, Ghula S, Aziz JMA, Makram AM, et al
    The efficacy and adverse effects of favipiravir on COVID-19 patients: a systematic review and meta-analysis of published clinical trials and observational studies.
    Int J Infect Dis. 2022 Apr 22. pii: S1201-9712(22)00237.
    >> Share

  130. PETRONE L, Picchianti-Diamanti A, Sebastiani GD, Aiello A, et al
    Humoral and cellular responses to spike of delta SARS-CoV-2 variant in vaccinated patients with Immune Mediated Inflammatory Diseases.
    Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00229.
    >> Share

  131. LIU Y, Yu Y, Zhao Y, He D, et al
    Reduction in the infection fatality rate of Omicron variant compared to previous variants in South Africa.
    Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00228.
    >> Share

  132. KOUTALOS AA, Stefanou N, Malizos KN
    Post-acute sequelae of SARS-CoV-2 infection. Osteonecrosis must not be overlooked.
    Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00226.
    >> Share

  133. JAHAN N, Brahma A, Kumar MS, Bagepally BS, et al
    Corrigendum to 'Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis' [International Journal of Infectious Diseases, Volume 116 (2022) P59-67].
    Int J Infect Dis. 2022;119:119.
    >> Share

  134. VOO TC, Ballantyne A, Jenn NC, Cowling BJ, et al
    Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey.
    Int J Infect Dis. 2022 Apr 14. pii: S1201-9712(22)00222.
    >> Share

  135. TEGELER CM, Bilich T, Maringer Y, Salih HR, et al
    Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort.
    Int J Infect Dis. 2022 Apr 14. pii: S1201-9712(22)00219.
    >> Share

  136. RAMIREZ C, Duron RM
    The Russia-Ukraine war could bring catastrophic public-health challenges beyond COVID-19.
    Int J Infect Dis. 2022 Apr 12. pii: S1201-9712(22)00215.
    >> Share

  137. TEMBO J, Egbe NF, Maluzi K, Mulonga K, et al
    Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia.
    Int J Infect Dis. 2022 Apr 12. pii: S1201-9712(22)00216.
    >> Share

  138. LIU K, Wang X, Song G
    Association of epicardial adipose tissue with the severity and adverse clinical outcomes of COVID-19: A meta-analysis.
    Int J Infect Dis. 2022 Apr 11. pii: S1201-9712(22)00212.
    >> Share

  139. JABAL KA, Edelstein M
    Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: Example from an Israeli Healthcare worker cohort.
    Int J Infect Dis. 2022 Apr 9. pii: S1201-9712(22)00209.
    >> Share

  140. WOLDAY D, de Wit TFR
    Response to Abdelrahman M et al commentary on "Parasites Protect from Severe COVID-19. Myth or Reality?"
    Int J Infect Dis. 2022 Apr 9. pii: S1201-9712(22)00211.
    >> Share

  141. SOMAN R, Chakraborty S, Joe G
    Posaconazole or Isavuconazole as sole or predominant anti-fungal therapy for COVID-19 associated Mucormycosis. A retrospective observational case series.
    Int J Infect Dis. 2022 Apr 8. pii: S1201-9712(22)00208.
    >> Share

  142. HAMBRIDGE HL, Kahn R, Onnela JP
    Effect of a Two-Dose vs Three-Dose Vaccine Strategy in Residential Colleges Using an Empirical Proximity Network.
    Int J Infect Dis. 2022 Apr 8. pii: S1201-9712(22)00206.
    >> Share

  143. DI LEGO V, Sanchez-Romero M, Prskawetz A
    The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00197.
    >> Share

  144. HO LL, Gurung S, Mirza I, Nicolas HD, et al
    Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00204.
    >> Share

  145. WANG X, Wei J, Zhu R, Chen L, et al
    Contribution of CD4+ T cell mediated inflammation to diarrhoea in patients with COVID-19.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00201.
    >> Share

  146. MEDHAT R, El Lababidi R, Abdelsalam M, Nusair A, et al
    Varicella Zoster Virus (VZV) Meningitis in an Immunocompetent Adult following BNT162b2 mRNA COVID-19 Vaccination: A Case Report.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00200.
    >> Share

    March 2022
  147. BURANASAKDA M, Kotruchin P, Phanthachai K, Mootsikapun P, et al
    Varicella zoster meningitis following COVID-19 vaccination: a report of two cases.
    Int J Infect Dis. 2022 Mar 30. pii: S1201-9712(22)00192.
    >> Share

  148. KLOPFENSTEIN T, Tipirdamaz C, Gendrin V, Osman M, et al
    Third of patients have gustatory dysfunction 9 months after SARS-CoV-2 infection: the ANOSVID study.
    Int J Infect Dis. 2022 Mar 29. pii: S1201-9712(22)00193.
    >> Share

  149. JEGERLEHNER S, Suter-Riniker F, Jent P, Bittel P, et al
    Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting.
    Int J Infect Dis. 2022 Mar 29. pii: S1201-9712(22)00176.
    >> Share

  150. GHOSH A, Walia S, Rattan R, Kanampalliwar A, et al
    Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India.
    Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00181.
    >> Share

  151. ARKELL P, Gusmao C, Sheridan SL, Tanesi MY, et al
    Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste.
    Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00183.
    >> Share

  152. JACKSON I, Jaradeh H, Aurit S, Aldamen A, et al
    Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19.
    Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00179.
    >> Share

  153. ABU-ODAH H, Su JJ, Musa SS
    Unwillingness or reluctance of Palestinians to get COVID-19 vaccine: the reasons behind it and how to persuade them.
    Int J Infect Dis. 2022 Mar 25. pii: S1201-9712(22)00178.
    >> Share

  154. CHANDA-KAPATA P, Ntoumi F, Kapata N, Lungu P, et al
    Tuberculosis, HIV/AIDS and Malaria Health Services in sub-Saharan Africa - A Situation Analysis of the Disruptions and Impact of the COVID-19 Pandemic.
    Int J Infect Dis. 2022 Mar 24. pii: S1201-9712(22)00173.
    >> Share

  155. KIM AY, Woo W, Yon DK, Lee SW, et al
    Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2022 Mar 23. pii: S1201-9712(22)00171.
    >> Share

  156. LI R, Liu H, Fairley CK, Zou Z, et al
    Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States.
    Int J Infect Dis. 2022 Mar 22. pii: S1201-9712(22)00168.
    >> Share

  157. SUAH JL, Husin M, Keng PS, Hwa B, et al
    Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study.
    Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00167.
    >> Share

  158. GUO Q, Wang J, Estill J, Lan H, et al
    Risk of COVID-19 Transmission Aboard Aircraft: An Epidemiological Analysis Based on the National Health Information Platform.
    Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00163.
    >> Share

  159. MAKRAM AM, Alied M, Khan ZA, Huy NT, et al
    Parasites Protect from Severe COVID-19. Myth or Reality?
    Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00164.
    >> Share

  160. JEREMIAH C, Petersen E, Nantanda R, Mungai BN, et al
    The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.
    Int J Infect Dis. 2022 Mar 20. pii: S1201-9712(22)00149.
    >> Share

  161. SHANAUBE K, Schaap A, Klinkenberg E, Floyd S, et al
    SARS-CoV-2 seroprevalence and associated risk factors in peri-urban Zambia: a population-based study.
    Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00158.
    >> Share

  162. INADA M, Ishikane M, Terada M, Matsunaga A, et al
    Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection.
    Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00155.
    >> Share

  163. ONO A, Koizumi R, Tsuzuki S, Asai Y, et al
    Antimicrobial Use Fell Substantially in Japan in 2020-The COVID-19 Pandemic May Have Played a Role.
    Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00157.
    >> Share

  164. ELEC F, Magnusson J, Elec A, Muntean A, et al
    COVID-19 AND KIDNEY TRANSPLANTATION: THE IMPACT OF REMDESIVIR ON RENAL FUNCTION AND OUTCOME- A RETROSPECTIVE COHORT STUDY.
    Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00151.
    >> Share

  165. NTOUMI F, Petersen E, Mwaba P, Aklillu E, et al
    Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.: Invited viewpoint: IJID World TB Day series 2022.
    Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00150.
    >> Share

  166. O'KELLY B, Vidal L, Avramovic G, Broughan J, et al
    Assessing the impact of COVID-19 at 1 year using the SF-12 questionnaire: Data from the Anticipate longitudinal cohort study.
    Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00152.
    >> Share

  167. MATTIUZZI C, Henry BM, Lippi G
    COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
    Int J Infect Dis. 2022 Mar 9. pii: S1201-9712(22)00146.
    >> Share

  168. LEE DS, Kim JW, Lee KL, Jung YJ, et al
    Adverse events following coronavirus disease 2019 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study.
    Int J Infect Dis. 2022 Mar 8. pii: S1201-9712(22)00145.
    >> Share

  169. GLINERT I, Ben-Shmuel A, Szwartcwort-Cohen M, Beth-Din A, et al
    Revisiting SARS-CoV-2 environmental contamination by COVID-19 patients: The Omicron variant does not differ from previous strains.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00139.
    >> Share

  170. LIU ZG, Li XY
    Interpretation of Discrepancies between Cities in the Transmission of COVID-19: Evidence from China in the First Weeks of the Pandemic: Interpreting the Discrepancies of COVID-19 Transmission.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00142.
    >> Share

  171. MORENO-GARCIA E, Puerta-Alcalde P, Letona L, Meira F, et al
    Bacterial co-infection at hospital admission in patients with COVID-19.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00143.
    >> Share

  172. ADRIEN CSK, Alexandre C, Marie M, Cedric J, et al
    Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patients.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00141.
    >> Share

  173. RODRIGUEZ GD, Wu Y, Karnik K, Ruddy S, et al
    Implementation of a Collaborated Antimicrobial Stewardship Program and Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit-driven Monoclonal Antibody Therapy Program for COVID-19 at a NYC Hospital.
    Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00137.
    >> Share

  174. ASSAL HH, Abdelrahman S, Abdelbasset MA, Abdelaziz M, et al
    Presepsin as a Novel Biomarker in predicting Inhospital Mortality in COVID-19 Pneumonia Patients.
    Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00136.
    >> Share

  175. PETERSEN E, Al-Abri S, Chakaya J, Goletti D, et al
    World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic.
    Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00138.
    >> Share

  176. MUSSO N, Maugeri JG, Bongiorno D, Stracquadanio S, et al
    SARS-CoV-2's high rate of genetic mutation under immune selective pressure: from oropharyngeal B.1.1.7 to intrapulmonary B.1.533 in a post-vaccine patient.
    Int J Infect Dis. 2022 Mar 2. pii: S1201-9712(22)00123.
    >> Share

  177. LAYER E, Hoehl S, Ciesek S, Widera M, et al
    SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach.
    Int J Infect Dis. 2022 Mar 2. pii: S1201-9712(22)00121.
    >> Share

  178. EFIMENKO I, Nackeeran S, Jabori S, Zamora JAG, et al
    REMOVED: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database.
    Int J Infect Dis. 2022;116S:S40.
    >> Share

    February 2022
  179. HUSSEY H, Davies MA, Heekes A, Williamson C, et al
    Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis.
    Int J Infect Dis. 2022 Feb 27. pii: S1201-9712(22)00129.
    >> Share

  180. SHURRAB FM, Younes N, Al-Sadeq DW, Liu N, et al
    Performance evaluation of novel fluorescent-based lateral immune flow assay (LIFA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals.
    Int J Infect Dis. 2022 Feb 26. pii: S1201-9712(22)00130.
    >> Share

  181. ROUAMBA T, Ouedraogo E, Barry H, Yameogo NV, et al
    Assessment of Recovery Time, Worsening and Death, among COVID-19 inpatients and outpatients, under treatment with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso.
    Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00111.
    >> Share

  182. ALBAHRANI S, Ahmadi NA, Hamdan S, Elsheikh N, et al
    Clinical Presentation and Outcome of hospitalized patients with COVID-19 in the first and second wave in Saudi Arabia.
    Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00127.
    >> Share

  183. THEOHARIDES TC, Guerra L, Patel K
    Successful Treatment of a Severe COVID-19 Patient Using an Integrated Approach Addressing Mast Cells and Their Mediators.
    Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00128.
    >> Share

  184. HIRATA M, Fukuchi T, Sugawara H
    Trajectory of SARS-CoV-2 anti-S IgG levels following transfusion and a third dose of BNT162b2 vaccine in a patient with massive postoperative bleeding: A case report.
    Int J Infect Dis. 2022 Feb 24. pii: S1201-9712(22)00122.
    >> Share

  185. XIE M, Dong N, Zhang X, He D, et al
    Exported Cases were Infected on the Way: A Conjecture Derived from Analysis on Hong Kong Monthly Exported Covid-19 Cases.
    Int J Infect Dis. 2022 Feb 23. pii: S1201-9712(22)00102.
    >> Share

  186. ROSENTHAL VD, Myatra SN, Divatia JV, Biswas S, et al
    The impact of COVID-19 on healthcare-associated infections in intensive care units in low and middle income countries: International Nosocomial Infection Control Consortium (INICC) findings.
    Int J Infect Dis. 2022 Feb 23. pii: S1201-9712(22)00120.
    >> Share

  187. LITCHFIELD M, Brookes P, Ojrzynska A, Kavi J, et al
    Comparison of the clinical sensitivity and specificity of two commercial RNA SARS-CoV-2 assays.
    Int J Infect Dis. 2022 Feb 22. pii: S1201-9712(22)00109.
    >> Share

  188. VICKERS DM, Baral S, Mishra S, Kwong JC, et al
    Stringency of Containment and Closures on the Growth of SARS-CoV-2 in Canada prior to Accelerated Vaccine Roll-Out.
    Int J Infect Dis. 2022 Feb 21. pii: S1201-9712(22)00108.
    >> Share

  189. CUCUNAWANGSIH C, Wijaya RS, Lugito NPH, Suriapranata I, et al
    Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00114.
    >> Share

  190. TSUZUKI S, Hayakawa K, Uemura Y, Shinozaki T, et al
    Efficacy of remdesivir in hospitalized nonsevere COVID-19 patients in Japan: A large observational study using the COVID-19 Registry Japan.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00118.
    >> Share

  191. DIAS R, Caldas JP, Silva-Pinto A, Costa A, et al
    Delirium severity in critical COVID-19 patients from an Infectious Disease Intensive Care Unit.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00112.
    >> Share

  192. DHUMAL S, Patil A, More A, Kamtalwar S, et al
    SARS-COV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00115.
    >> Share

  193. GRAVNINGEN K, Henriksen S, Hungnes O, Svendsen K, et al
    Risk factors, immune response and whole-genome sequencing of SARS-CoV-2 in a cruise ship outbreak in Norway.
    Int J Infect Dis. 2022 Feb 18. pii: S1201-9712(22)00104.
    >> Share

  194. KAMURA Y, Terao T, Akao S, Kono Y, et al
    Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine: A case report.
    Int J Infect Dis. 2022 Feb 18. pii: S1201-9712(22)00107.
    >> Share

  195. MORITA Y, Kurano M, Jubishi D, Ikeda M, et al
    Urine sediment findings were milder in patients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renal injuries.
    Int J Infect Dis. 2022 Feb 16. pii: S1201-9712(22)00101.
    >> Share

  196. KAKINOKI Y, Yamada K, Tanino Y, Suzuki K, et al
    Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for Covid-19 patients in A Real-Life Setting: A Single Institute Analysis.
    Int J Infect Dis. 2022 Feb 14. pii: S1201-9712(22)00076.
    >> Share

  197. FALTIN K, Lewandowska Z, Malecki P, Czyz K, et al
    SARS-CoV-2 attacks the weakest point - COVID-19 course in a pediatric patient with Friedreich's ataxia.
    Int J Infect Dis. 2022 Feb 13. pii: S1201-9712(22)00098.
    >> Share

  198. MORENO-PEREZ O, Ribes I, Boix V, Martinez-Garcia MA, et al
    Hospitalized patients with breakthrough COVID-19: Clinical features and poor outcome predictors.
    Int J Infect Dis. 2022 Feb 13. pii: S1201-9712(22)00084.
    >> Share

  199. HAFEZ W, Ziade MA, Arya A, Saleh H, et al
    Reduced ADAMTS13 Activity in Correlation with Pathophysiology, Severity, and Outcome of COVID-19; A Retrospective Observational Study.
    Int J Infect Dis. 2022 Feb 12. pii: S1201-9712(22)00097.
    >> Share

  200. MURILLO-ZAMORA E, Sanchez-Pina RA, Trujillo X, Huerta M, et al
    Independent risk factors of COVID-19 pneumonia in vaccinated Mexican adults.
    Int J Infect Dis. 2022 Feb 12. pii: S1201-9712(22)00078.
    >> Share

  201. FINSTERER J, Matovu D
    Exclude differentials before diagnosing SARS-CoV-2 assocaited acute, hemorrhaghic, necrotising encephalitis.
    Int J Infect Dis. 2022 Feb 10. pii: S1201-9712(22)00094.
    >> Share

  202. MIERZEWSKA-SCHMIDT M, Baranowski A, Szymanska K, Ciaston M, et al
    Authors' response to Dr Finsterer's comment "Exclude differentials before diagnosing SARS-CoV-2 associated acute, hemorrhaghic, necrotising encephalitis".
    Int J Infect Dis. 2022 Feb 10. pii: S1201-9712(22)00092.
    >> Share

  203. KOJIMA N, Roshani A, Brobeck M, Baca A, et al
    Incidence of Severe Acute Respiratory Syndrome Coronavirus-2 infection among previously infected or vaccinated employees.
    Int J Infect Dis. 2022 Feb 10. pii: S1201-9712(22)00091.
    >> Share

  204. BIRGAND G, Charani E, Ahmad R, Bonaconsa C, et al
    Interventional research to tackle antimicrobial resistance in Low Middle Income Countries in the era of the COVID-19 pandemic: lessons in resilience from an international consortium.
    Int J Infect Dis. 2022 Feb 9. pii: S1201-9712(22)00090.
    >> Share

  205. FERNANDEZ-DE-LAS-PENAS C, Martin-Guerrero JD, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, et al
    Exploring the Trajectory Recovery Curve of the number of Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study.
    Int J Infect Dis. 2022 Feb 9. pii: S1201-9712(22)00083.
    >> Share

  206. VICIANI E, Gaibani P, Castagnetti A, Liberatore A, et al
    Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients.
    Int J Infect Dis. 2022 Feb 9. pii: S1201-9712(22)00088.
    >> Share

  207. MONTANO MA, Bemer MJ, Heller KB, Meisner A, et al
    Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral culture.
    Int J Infect Dis. 2022 Feb 8. pii: S1201-9712(22)00086.
    >> Share

  208. GARGOURI S, Abid N, Karray-Hakim H, Rebai A, et al
    Reply to letter to the editor by Lippi and Plebani: << The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization >> (THEIJID-D-22-00085).
    Int J Infect Dis. 2022 Feb 6. pii: S1201-9712(22)00067.
    >> Share

  209. LIU N, Yang D, Zhang T, Sun J, et al
    Systematic review and meta-analysis of olfactory and gustatory dysfunction in coronavirus disease 2019.
    Int J Infect Dis. 2022 Feb 5. pii: S1201-9712(22)00079.
    >> Share

  210. AVERHOFF F, Berg M, Rodgers M, Osmanov S, et al
    The Abbott Pandemic Defense Coalition: a unique multi-sector approach adds to global pandemic preparedness efforts.
    Int J Infect Dis. 2022 Feb 5. pii: S1201-9712(22)00080.
    >> Share

  211. LIM RHF, Htun HL, Li AL, Guo H, et al
    Fending off Delta - Hospital measures to reduce nosocomial transmission of COVID-19.
    Int J Infect Dis. 2022 Feb 3. pii: S1201-9712(22)00077.
    >> Share

  212. XIE H, Wen X, Li J, Chen W, et al
    Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for Coronavirus Disease 2019 (COVID-19) Variants after Primary and Booster Immunization.
    Int J Infect Dis. 2022 Feb 2. pii: S1201-9712(22)00075.
    >> Share

  213. MARZOUK M, Alhiraki OA, Aguas R, Gao B, et al
    SARS-CoV-2 transmission in opposition-controlled Northwest Syria: modelling pandemic responses during political conflict.
    Int J Infect Dis. 2022 Feb 2. pii: S1201-9712(22)00071.
    >> Share

  214. ZHANG H, Liu X, Liu Q, Mei H, et al
    Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay.
    Int J Infect Dis. 2022 Feb 1. pii: S1201-9712(22)00069.
    >> Share

  215. JONES T, Marimuthu K, Bearman G
    Virtual Infection Prevention and Control in Low- and Middle-Income Countries.
    Int J Infect Dis. 2022 Feb 1. pii: S1201-9712(22)00074.
    >> Share

    January 2022
  216. LIU B, Su X, Yu G, Yang S, et al
    Corrigendum to 'An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccines ' [International Journal of Infectious Diseases, Volume 115, 2022, Pages 116-125, ISSN 1201-9712].
    Int J Infect Dis. 2022 Jan 31. pii: S1201-9712(22)00045.
    >> Share

  217. LIPPI G, Plebani M
    The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization.
    Int J Infect Dis. 2022 Jan 31. pii: S1201-9712(22)00066.
    >> Share

  218. MUSA SS, Zhao S, Abdullahi ZU, Habib AG, et al
    COVID-19 and Lassa fever in Nigeria: A deadly alliance?
    Int J Infect Dis. 2022 Jan 30. pii: S1201-9712(22)00065.
    >> Share

  219. ZHA L, Sobue T, Hirayama A, Takeuchi T, et al
    Characteristics and Outcomes of COVID-19 in Reproductive-Aged Pregnant and Non-Pregnant Women in Osaka, Japan.
    Int J Infect Dis. 2022 Jan 29. pii: S1201-9712(22)00063.
    >> Share

  220. MA X, Wu K, Li Y, Li S, et al
    Contact tracing period and epidemiological characteristics of an outbreak by SARS-CoV-2 Delta variant in Guangzhou.
    Int J Infect Dis. 2022 Jan 28. pii: S1201-9712(22)00036.
    >> Share

  221. WEE LE, Conceicao EP, Sim JX, Venkatachalam I, et al
    Correspondence on "The Low Yield of SARS-CoV-2 Rapid Antigen Testing in Screening Asymptomatic Hospital Visitors in Low-incidence Settings".
    Int J Infect Dis. 2022 Jan 27. pii: S1201-9712(22)00057.
    >> Share

  222. RADULESCU A, Istrate A, Muntean M
    Treatment with Tocilizumab in Adult Patients with Moderate to Critical COVID-19 Pneumonia: A Single-Center Retrospective Study.
    Int J Infect Dis. 2022 Jan 27. pii: S1201-9712(22)00056.
    >> Share

  223. BODDETI NL, Berezowski I, Taylor D, Prajapati D, et al
    The Low Yield of SARS-CoV-2 Rapid Antigen Testing in Screening Asymptomatic Hospital Visitors in Low-incidence Settings.
    Int J Infect Dis. 2022 Jan 27. pii: S1201-9712(22)00054.
    >> Share

  224. SAN-JUAN R, Fernandez-Ruiz M, Lopez-Medrano F, Carretero O, et al
    Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.
    Int J Infect Dis. 2022 Jan 23. pii: S1201-9712(22)00050.
    >> Share

  225. HONGE BL, Hindhede L, Kaspersen KA, Harritshoj LH, et al
    Long-term detection of SARS-CoV-2 antibodies after infection and risk of re-infection.
    Int J Infect Dis. 2022 Jan 22. pii: S1201-9712(22)00046.
    >> Share

  226. JURAJ S, Martin K, Kristina B, Samuel N, et al
    COVID-19 pneumonia patients with 25(OH)D levels lower than 12 ng/ml are at increased risk of death.
    Int J Infect Dis. 2022 Jan 22. pii: S1201-9712(22)00052.
    >> Share

  227. KOYAMA AK, Koumans EH, Sircar K, Lavery A, et al
    Severe Outcomes, Readmission, and Length of Stay Among COVID-19 Patients with Intellectual and Developmental Disabilities.
    Int J Infect Dis. 2022 Jan 22. pii: S1201-9712(22)00048.
    >> Share

  228. LUO T, Wang J, Wang Q, Wang X, et al
    Reconstruction of the Transmission Chain of COVID-19 Outbreak in Beijing's Xinfadi Market, China.
    Int J Infect Dis. 2022 Jan 21. pii: S1201-9712(22)00037.
    >> Share

  229. MORENO-TORRES V, Munoz A, Calderon-Parra J, Mills-Sanchez P, et al
    Mortality by Covid-19 Prior to Vaccination - One Year Experience of Hospitalized Patients in Madrid.
    Int J Infect Dis. 2022 Jan 21. pii: S1201-9712(22)00049.
    >> Share

  230. KO YK, Furuse Y, Ninomiya K, Otani K, et al
    Secondary transmission of SARS-CoV-2 during the first two waves in Japan: Demographic characteristics and overdispersion.
    Int J Infect Dis. 2022 Jan 20. pii: S1201-9712(22)00034.
    >> Share

  231. PEREIRA DN, Silveira LFG, Guimaraes MMM, Polanczyk CA, et al
    Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry.
    Int J Infect Dis. 2022 Jan 19. pii: S1201-9712(22)00016.
    >> Share

  232. AMIYA S, Fujimoto J, Matsumoto K, Yamamoto M, et al
    Case report: Acute exacerbation of interstitial pneumonia related to mRNA COVID-19 vaccination.
    Int J Infect Dis. 2022 Jan 19. pii: S1201-9712(22)00032.
    >> Share

  233. HU Z, Tao B, Li Z, Song Y, et al
    Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China.
    Int J Infect Dis. 2022 Jan 19. pii: S1201-9712(22)00033.
    >> Share

  234. NAKANISHI Y, Honda S, Yamano M, Kawasaki T, et al
    Constrictive pericarditis after SARS-CoV-2 vaccination: A case report.
    Int J Infect Dis. 2022 Jan 18. pii: S1201-9712(22)00027.
    >> Share

  235. LUCIENA CMO, Lenzoni F, Suarez MV, Duarte AA, et al
    Hypersensitivity reaction to hyaluronic acid dermal filler after vaccination against COVID-19: A series of cases in Sao Paulo, Brazil.
    Int J Infect Dis. 2022 Jan 18. pii: S1201-9712(22)00029.
    >> Share

  236. TARDIF JC, Cossette M, Guertin MC, Bouabdallaoui N, et al
    Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19.
    Int J Infect Dis. 2022 Jan 14. pii: S1201-9712(22)00021.
    >> Share

  237. MOLLER IJB, Utke AR, Rysgaard UK, Ostergaard LJ, et al
    Diagnostic performance, user acceptability, and safety of unsupervised SARS-CoV-2 rapid antigen detecting tests performed at home.
    Int J Infect Dis. 2022 Jan 14. pii: S1201-9712(22)00020.
    >> Share

  238. KRIGER O, Gefen-Halevi S, Leshem E, Smollan G, et al
    Viral co-pathogens in COVID-19 acute respiratory syndrome - what did we learn from the first year of pandemic?
    Int J Infect Dis. 2022 Jan 13. pii: S1201-9712(22)00018.
    >> Share

  239. ISMAIL N, Hassan N, Hamid MHNA, Yusoff UN, et al
    ASSOCIATION OF SMOKING AND SEVERITY OF COVID-19 INFECTION AMONG 5889 PATIENTS IN MALAYSIA: A MULTI-CENTRE OBSERVATIONAL STUDY.
    Int J Infect Dis. 2022 Jan 9. pii: S1201-9712(22)00012.
    >> Share

  240. ZHANG Z, Lin F, Liu F, Li Q, et al
    Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and COPD: A distinctive molecular signature for critically ill COVID-19 patients.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00001.
    >> Share

  241. GARGOURI S, Souissi A, Abid N, Chtourou A, et al
    Evidence of SARS-CoV-2 Symptomatic Reinfection in Four Health Care Professionals from the Same Hospital Despite the Presence of Antibodies.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00005.
    >> Share

  242. WU H, Dai R, He P, Liang J, et al
    Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00015.
    >> Share

  243. FERNANDEZ-DE-LAS-PENAS C, Pellicer-Valero OJ, Navarro-Pardo E, Palacios-Cena D, et al
    Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00007.
    >> Share

  244. YIN Y, Gao J, Zhang Y, Zhang X, et al
    Evaluation of reporting quality of abstracts of randomized controlled trials regarding patients with COVID-19 using the CONSORT statement for abstracts.
    Int J Infect Dis. 2022 Jan 6. pii: S1201-9712(22)00003.
    >> Share

  245. NOVAZZI F, Baj A, Pasciuta R, Genoni A, et al
    A CLUSTER OF SARS-COV-2 DELTA VARIANT OF CONCERN ADDITIONALLY HARBORING F490S, NORTHERN LOMBARDY, ITALY.
    Int J Infect Dis. 2022 Jan 4. pii: S1201-9712(21)01258.
    >> Share

  246. DRAGO F, Broccolo F, Ciccarese G
    Comment on a case of pityriasis rosea shortly after Moderna COVID-19 vaccination.
    Int J Infect Dis. 2022 Jan 3. pii: S1201-9712(21)01260.
    >> Share

  247. YAKOVLEV AS, Belyaletdinova IK, Mazankova LN, Samitova ER, et al
    SARS-CoV-2 infection in children in Moscow in 2020: clinical features and impact on circulation of other respiratory viruses.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01216.
    >> Share

  248. KOHANOVSKI I, Obolski U, Ram Y
    Inferring the effective start dates of non-pharmaceutical interventions during COVID-19 outbreaks.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01262.
    >> Share

  249. MARTINOT M
    Should remdesivir be recommended in France in the early stage of COVID-19.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01259.
    >> Share

  250. CURCIO R, Gandolfo V, Alcidi R, Giacomino L, et al
    VACCINE-INDUCED MASSIVE PULMONARY EMBOLISM AND THROMBOCYTOPENIA FOLLOWING A SINGLE DOSE OF JANSSEN AD26.COV2.S VACCINATION.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01244.
    >> Share

  251. BAOS E, Delgado-Iribarren A, O Connor S, Bardon I, et al
    Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection.
    Int J Infect Dis. 2022;114:85-87.
    >> Share

    December 2021
  252. GROBUSCH LC, Grobusch MP
    A hot topic at the environment-health nexus: Investigating the impact of climate change on infectious diseases.
    Int J Infect Dis. 2021 Dec 29. pii: S1201-9712(21)01250.
    >> Share

  253. CALDERON-PARRA J, Cuervas-Mons V, Moreno-Torres V, Rubio-Rivas M, et al
    Influence of chronic corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: Analysis of a nationwide registry.
    Int J Infect Dis. 2021 Dec 28. pii: S1201-9712(21)01222.
    >> Share

  254. ABDULLAH F, Myers J, Basu D, Tintinger G, et al
    Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa.
    Int J Infect Dis. 2021 Dec 28. pii: S1201-9712(21)01256.
    >> Share

  255. DAYANAND D, Irudhayanathan I, Kundu D, Manesh A, et al
    Community seroprevalence and risk factors for SARS CoV-2 infection in different subpopulations in Vellore, India and its implications for future prevention.
    Int J Infect Dis. 2021 Dec 28. pii: S1201-9712(21)01255.
    >> Share

  256. JAHAN N, Brahma A, Kumar MS, Bagepally BS, et al
    Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis.
    Int J Infect Dis. 2021 Dec 27. pii: S1201-9712(21)01251.
    >> Share

  257. CHAN EWW, Leung MTY, Lau LKW, Leung J, et al
    Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA Covid-19 vaccine: a prospective cohort study.
    Int J Infect Dis. 2021 Dec 26. pii: S1201-9712(21)01253.
    >> Share

  258. HWANG J, Han YJ, Yon DK, Lee SW, et al
    Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01248.
    >> Share

  259. AFZAL A, Gutierrez VP, Gomez E, Mon AM, et al
    Bloodstream infections in hospitalized patients before and during the COVID-19 surge in a community hospital in the South Bronx.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01249.
    >> Share

  260. PROMLEK T, Thanunchai M, Phumisantiphong U, Hansirisathit T, et al
    Performance of colorimetric RT-LAMP as a diagnostic tool for SARS-CoV-2 infection during the fourth wave of COVID-19 in Thailand.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01252.
    >> Share

  261. CAKMAKLI C, Demiralp S, Ergonul O, Yesiltas S, et al
    The Role of Institutional, Cultural, and Economic Factors on the Effectiveness of the Lockdown Measures.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01233.
    >> Share

  262. LIEU A, Mah J, Church D
    A Case of Multisystem Inflammatory Syndrome in Adults Following Natural Infection and Subsequent Immunization.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01239.
    >> Share

  263. O'FEE JR, Li J, Chang JR
    Bell's Phenomenon is a normal finding, distinct from Bell's Palsy; Response to "Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database" by Sato et al.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01246.
    >> Share

  264. MCKINNON JE, Wang DD, Zervos M, Saval M, et al
    Safety and Tolerability of Hydroxychloroquine in healthcare workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study.
    Int J Infect Dis. 2021 Dec 22. pii: S1201-9712(21)01243.
    >> Share

  265. HOEFER A, Pampaka D, Castrillejo D, Luenga-Cabrera J, et al
    Considerations for COVID-19 management in reception centers for refugees, asylum seekers and migrants, Spain 2020.
    Int J Infect Dis. 2021 Dec 21. pii: S1201-9712(21)01240.
    >> Share

  266. CLAISE C, Saleh J, Rezek M, Vaulont S, et al
    Low Transferrin Levels Predict Heightened Inflammation in COVID-19 Patients: New Insights.
    Int J Infect Dis. 2021 Dec 21. pii: S1201-9712(21)01237.
    >> Share

  267. DIEZ JM, Romero C, Gajardo R
    Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.: Antibodies to common coronaviruses in IgG medicinal products.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01228.
    >> Share

  268. MIERZEWSKA-SCHMIDT M, Baranowski A, Szymanska K, Ciaston M, et al
    The case of fatal acute hemorrhagic necrotizing encephalitis in a two-month-old boy with Covid-19.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01232.
    >> Share

  269. BIN-GOUTH AS, Al-Shoteri S, Mahmoud N, Musani A, et al
    SARS-CoV-2 Seroprevalence in Aden, Yemen: A population-based study.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01229.
    >> Share

  270. MEINUS C, Singer R, Nandi B, Jagot O, et al
    SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01234.
    >> Share

  271. AYAZ A, Demir AGO, Ozturk G, Kocak M, et al
    A Pooled RT-PCR Testing Strategy for More Efficient Covid-19 Pandemic Management.
    Int J Infect Dis. 2021 Dec 15. pii: S1201-9712(21)01225.
    >> Share

  272. RUIZ-STERNBERG AM, Chaparro-Solano HM, Albornoz LLA, Pinzon-Rondon AM, et al
    GENOMIC CHARACTERIZATION OF SARS-CoV-2 AND ITS ASSOCIATION WITH CLINICAL OUTCOMES: A ONE-YEAR LONGITUDINAL STUDY OF THE PANDEMIC IN COLOMBIA.
    Int J Infect Dis. 2021 Dec 14. pii: S1201-9712(21)01220.
    >> Share

  273. KOSEKI T, Nakajima K, Iwasaki H, Yamada S, et al
    Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients.
    Int J Infect Dis. 2021 Dec 12. pii: S1201-9712(21)01219.
    >> Share

  274. KOBAYASHI T, Yoshii K, Linton NM, Suzuki M, et al
    Age dependence of the natural history of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An analysis of Diamond Princess data.
    Int J Infect Dis. 2021 Dec 10. pii: S1201-9712(21)01213.
    >> Share

  275. VENETI L, Salamanca BV, Seppala E, Starrfelt J, et al
    No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway.
    Int J Infect Dis. 2021 Dec 10. pii: S1201-9712(21)01218.
    >> Share

  276. TRAN LK, Huang DW, Li NK, Li LM, et al
    The impact of the COVID-19 preventive measures on influenza transmission: molecular and epidemiological evidence.
    Int J Infect Dis. 2021 Dec 10. pii: S1201-9712(21)01215.
    >> Share

  277. FINSTERER J, Scorza FA, Fiorini AC
    Impaired hearing following SARS-CoV-2 vaccinations.
    Int J Infect Dis. 2021 Dec 9. pii: S1201-9712(21)01209.
    >> Share

  278. LIU B, Su X, Yu G, Yang S, et al
    An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 Neutralizing antibody levels in COVID-19 patients and vaccinees.
    Int J Infect Dis. 2021 Dec 9. pii: S1201-9712(21)01207.
    >> Share

  279. GUREVICH M, Zilkha-Falb R, Sonis P, Magalashvili D, et al
    SARS-COV-2 Memory B and T Cells Profile in Mild COVID-19 Convalescents subjects.
    Int J Infect Dis. 2021 Dec 8. pii: S1201-9712(21)01203.
    >> Share

  280. DAVIES M, Bramwell LR, Jeffery N, Bunce B, et al
    Persistence of clinically-relevant levels of SARS-CoV2 envelope gene subgenomic RNAs in non-immunocompromised individuals.
    Int J Infect Dis. 2021 Dec 7. pii: S1201-9712(21)01206.
    >> Share

  281. YADAV SK, Zhao S, Akhter Y
    Response to Comments on "Preliminary estimation of the basic reproduction number of novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven Analysis in the early phase of the outbreak".
    Int J Infect Dis. 2021 Dec 5. pii: S1201-9712(21)01204.
    >> Share

  282. CLAPHAM HE, Chia WN, Tan LWL, Kumar V, et al
    Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population.
    Int J Infect Dis. 2021 Dec 2. pii: S1201-9712(21)00891.
    >> Share

  283. PETERSEN E, Ntoumi F, Hui DS, Abubakar A, et al
    Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.
    Int J Infect Dis. 2021 Dec 1. pii: S1201-9712(21)00888.
    >> Share

    November 2021
  284. RINDI LV, Moghazi SA, Donno DR, Cataldo MA, et al
    Predictive scores for the diagnosis of Pulmonary Embolism in COVID-19: A systematic review.
    Int J Infect Dis. 2021 Nov 27. pii: S1201-9712(21)00885.
    >> Share

  285. NGUYEN NN, Hoang VT, Dao TL, Meddeb L, et al
    Long-term persistence of symptoms of dyspnoea in COVID-19 patients.
    Int J Infect Dis. 2021 Nov 27. pii: S1201-9712(21)00882.
    >> Share

  286. JIAN MJ, Perng CL, Chung HY, Chang CK, et al
    Clinical assessment of SARS-CoV-2 antigen rapid detection compared with RT-PCR assay for emerging variants at a high-throughput community testing site in Taiwan.
    Int J Infect Dis. 2021 Nov 26. pii: S1201-9712(21)00883.
    >> Share

  287. LI H, Wu Q, Qin Z, Hou X, et al
    Serum levels of laminin and von Willebrand factor in COVID-19 survivors 6 months after discharge.
    Int J Infect Dis. 2021 Nov 26. pii: S1201-9712(21)00879.
    >> Share

  288. FAGYAS M, Fejes Z, Suto R, Nagy Z, et al
    Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients.
    Int J Infect Dis. 2021 Nov 25. pii: S1201-9712(21)00876.
    >> Share

  289. RAMACHANDRAN R, Bhosale V, Reddy H, Atam V, et al
    Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients.
    Int J Infect Dis. 2021 Nov 18. pii: S1201-9712(21)00872.
    >> Share

  290. ASAI S, Seki A, Akai Y, Tazawa H, et al
    Nationwide external quality assessment of SARS-CoV-2 nucleic acid amplification tests in Japan.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00869.
    >> Share

  291. FERNANDEZ LS, Iturriaga LAR, Yandiola PPE, Ocana RM, et al
    BACTERAEMIC PNEUMOCOCCAL PNEUMONIA AND SARS-CoV-2 PNEUMONIA: DIFFERENCES AND SIMILARITIES.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00871.
    >> Share

  292. ZOU Z, Fairley CK, Shen M, Scott N, et al
    Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00870.
    >> Share

  293. ZHENG C, Shao W, Chen X, Zhang B, et al
    Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00857.
    >> Share

  294. DOTAN A, Shoenfeld Y
    Post-COVID syndrome: the aftershock of SARS-CoV-2.
    Int J Infect Dis. 2021 Nov 13. pii: S1201-9712(21)00867.
    >> Share

  295. ALI MM, Malik SMMR, Ahmed AY, Bashir AM, et al
    Survival analysis of all critically ill patients with COVID-19 admitted to the main hospital in Mogadishu, Somalia, 30 March-12 June 2020: what interventions are proving effective in fragile states?
    Int J Infect Dis. 2021 Nov 12. pii: S1201-9712(21)00865.
    >> Share

  296. WEE LE, Conceicao EP, Sim JX, Venkatachalam I, et al
    Utilisation of SARS-CoV-2 rapid antigen assays in screening asymptomatic hospital visitors: mitigating the risk in low-incidence settings.
    Int J Infect Dis. 2021 Nov 9. pii: S1201-9712(21)00859.
    >> Share

  297. GHOSH P, Chowdhury R, Hossain ME, Hossain F, et al
    Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settings.
    Int J Infect Dis. 2021 Nov 7. pii: S1201-9712(21)00854.
    >> Share

  298. JIAN MJ, Chung HY, Chang CK, Lin JC, et al
    SARS-CoV-2 Variants with T135I Nucleocapsid Mutations may Affect Antigen Test Performance.
    Int J Infect Dis. 2021 Nov 7. pii: S1201-9712(21)00853.
    >> Share

  299. FAVAS C, Jarrett P, Ratnayake R, Watson OJ, et al
    Country differences in transmissibility, age distribution and case-fatality of SARS-CoV-2: a global ecological analysis.
    Int J Infect Dis. 2021 Nov 5. pii: S1201-9712(21)00850.
    >> Share

  300. ABOBAKER A, Idris MA, Ogunjimi O
    A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine.
    Int J Infect Dis. 2021 Nov 3. pii: S1201-9712(21)00848.
    >> Share

  301. MANOUANA GP, Maloum MN, Bikangui R, Oye Bingono SO, et al
    Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in Republic of Gabon.
    Int J Infect Dis. 2021 Nov 3. pii: S1201-9712(21)00846.
    >> Share

  302. SHIN SH, Hong JK, Hong SA, Li K, et al
    Pityriasis rosea shortly after mRNA-1273 COVID-19 vaccination.
    Int J Infect Dis. 2021 Nov 2. pii: S1201-9712(21)00844.
    >> Share

  303. VAN GORDON MM
    Regional differences in NPI efficacy and recommendations for Africa.
    Int J Infect Dis. 2021;112:235-236.
    >> Share

    October 2021
  304. HOEBEL J, Michalski N, Diercke M, Hamouda O, et al
    Emerging socioeconomic disparities in COVID-19-related deaths during the second pandemic wave in Germany.
    Int J Infect Dis. 2021 Oct 29. pii: S1201-9712(21)00832.
    >> Share

  305. KUCHINSKI KS, Nguyen J, Lee TD, Hickman R, et al
    Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens.
    Int J Infect Dis. 2021 Oct 29. pii: S1201-9712(21)00838.
    >> Share

  306. LANDSBERG HE, Turcinovic J, Sullivan M, Connor JH, et al
    Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster.
    Int J Infect Dis. 2021 Oct 29. pii: S1201-9712(21)00840.
    >> Share

  307. LEUNG WF, Chorlton S, Tyson J, Al-Rawahi GN, et al
    COVID-19 in an Immunocompromised Host: Persistent Shedding of Viable SARS-CoV-2 and Emergence of Multiple Mutations, a Case Report.
    Int J Infect Dis. 2021 Oct 28. pii: S1201-9712(21)00829.
    >> Share

  308. BOGERE N, Bongomin F, Katende A, Ssebambulidde K, et al
    Performance and Cost-Effectiveness of a Pooled-Testing Strategy for SARS-CoV-2 Using Real-Time Polymerase Chain Reaction in Uganda.
    Int J Infect Dis. 2021 Oct 28. pii: S1201-9712(21)00834.
    >> Share

  309. PENETRA SLS, da Silva MFB, Resende P, Pina-Costa A, et al
    Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil.
    Int J Infect Dis. 2021 Oct 28. pii: S1201-9712(21)00836.
    >> Share

  310. DESAI A, Desai P, Mehta J, Sachora W, et al
    "Measuring the Impact of single dose of ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre".
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00819.
    >> Share

  311. HOU X, Fan W, Wang G, Chen X, et al
    T cell receptor repertoires as potential diagnostic markers for patients with COVID-19.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00820.
    >> Share

  312. RIEDEL PG, Sakai VF, Castro Cardoso Toniasso S, Brum MCB, et al
    Heart failure secondary to myocarditis after SARS-CoV-2 reinfection: a case report.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00822.
    >> Share

  313. FEKADU G, Jiang X, Yao J, You JHS, et al
    Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during COVID-19 pandemic in a high-income country.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00817.
    >> Share

  314. AMARSY R, Trystram D, Cambau E, Monteil C, et al
    Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00821.
    >> Share

  315. ASANO M, Okada H, Itoh Y, Hirata H, et al
    Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: A double-blind, randomized controlled phase 1/2 trial.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00818.
    >> Share

  316. DAHAL S, Luo R, Swahn MH, Chowell G, et al
    Geospatial Variability in Excess Death Rates during the COVID-19 Pandemic in Mexico: Examining Socio Demographic, Climate and Population Health Characteristics.
    Int J Infect Dis. 2021 Oct 19. pii: S1201-9712(21)00814.
    >> Share

  317. THIRION-ROMERO DI, Guerrero-Zuniga DS, Arias-Mendoza DA, Cornejo-Juarez DDP, et al
    EVALUATION OF PANBIO RAPID ANTIGEN TEST FOR SARS-CoV-2 IN SYMPTOMATIC PATIENTS AND THEIR CONTACTS: A MULTICENTER STUDY.
    Int J Infect Dis. 2021 Oct 19. pii: S1201-9712(21)00811.
    >> Share

  318. JEONG J, Choi HS
    Sudden sensorineural hearing loss after COVID-19 vaccination.
    Int J Infect Dis. 2021 Oct 17. pii: S1201-9712(21)00815.
    >> Share

  319. BRANDAO AAGS, de Oliveira CZ, Rojas SO, Ordinola AAM, et al
    Thromboembolic and bleeding events in ICU patients with COVID-19: results from a Brazilian tertiary hospital.
    Int J Infect Dis. 2021 Oct 17. pii: S1201-9712(21)00812.
    >> Share

  320. BOZZI G, Lombardi A, Ludovisi S, Muscatello A, et al
    TRANSIENT INCREASE OF PLASMA HIV RNA AFTER COVID-19 VACCINATION WITH mRNA-1272.
    Int J Infect Dis. 2021 Oct 16. pii: S1201-9712(21)00806.
    >> Share

  321. HASAN ZT, Atrakji DMQYMAA, Mehuaiden DAK
    The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00798.
    >> Share

  322. HERIYANTO RS, Kurniawan A, Wijovi F, Halim DA, et al
    The role of COVID-19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after sinovac vaccine administration on clinical year medical student in Indonesia.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00797.
    >> Share

  323. MASAI AN, Akin PL
    Practice of COVID-19 preventive measures and risk of acute respiratory infections: a longitudinal study in students from 95 countries.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00803.
    >> Share

  324. SPICER KB, Glick C, Cavanaugh AM, Thoroughman D, et al
    Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) - Kentucky, USA, 2020.
    Int J Infect Dis. 2021 Oct 11. pii: S1201-9712(21)00800.
    >> Share

  325. LUO G, Zhang X, Zheng H, He D, et al
    Infection fatality ratio and case fatality ratio of COVID-19.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00793.
    >> Share

  326. GIOVACCHINI N, Coppi M, Aiezza N, Baccani I, et al
    Rapid screening for SARS-CoV-2 VOC Alpha (202012/01, B.1.1.7) using the Allplex SARS-CoV-2 / FluA / FluB / RSV Assay.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00792.
    >> Share

  327. ANDRADE MC, Bonan PRF, Hilan E, Marques NP, et al
    COVID-19 Pandemic Causes Increased Clinic Visits with Diagnosis of Tegumentary Leishmaniasis in Brazil in 2020.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00795.
    >> Share

  328. RAMIREZ-ROSAS A, Benitez-Guerrero T, Corona-Cervantes K, Velez-Ixta JM, et al
    Study of perinatal transmission of SARS-CoV-2 in a Mexican public hospital.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00790.
    >> Share

  329. JUNG SM, Endo A, Akhmetzhanov AR, Nishiura H, et al
    Predicting the effective reproduction number of COVID-19: Inference using human mobility, temperature, and risk awareness.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00794.
    >> Share

  330. PIERCE J, Stevens MP
    COVID-19 and Antimicrobial Stewardship: Lessons Learned, Best Practices and Future Implications.
    Int J Infect Dis. 2021 Oct 5. pii: S1201-9712(21)00789.
    >> Share

  331. HAMBRIDGE HL, Kahn R, Onnela JP
    Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical Network.
    Int J Infect Dis. 2021 Oct 5. pii: S1201-9712(21)00796.
    >> Share

  332. CUCUNAWANGSIH C, Wijaya RS, Lugito NPH, Suriapranata I, et al
    Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.
    Int J Infect Dis. 2021 Oct 3. pii: S1201-9712(21)00787.
    >> Share

  333. BERTIN D, Kaphan E, Weber S, Babacci B, et al
    Persistent IgG anti-cardiolipin autoantibodies are associated with post-covid syndrome.
    Int J Infect Dis. 2021 Oct 3. pii: S1201-9712(21)00788.
    >> Share

  334. ZIMMERMANN IR, Sanchez MN, Alves LC, Frio GS, et al
    COVID-19 as a leading cause of hospitalizations with death in the Brazilian Public Health System in 2020.
    Int J Infect Dis. 2021 Oct 1. pii: S1201-9712(21)00785.
    >> Share

    September 2021
  335. PAN L, Zhang Y, Cui Y, Wu X, et al
    Bilateral uveitis after inoculation with COVID-19 vaccine: A case report.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00779.
    >> Share

  336. AL-ABRI SS, Al-Wahaibi A, Al-Kindi H, Kurup PJ, et al
    SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00770.
    >> Share

  337. ROQUEBERT B, Haim-Boukobza S, Trombert-Paolantoni S, Lecorche E, et al
    SARS-CoV-2 variants of concern are associated with lower RT-PCR amplification cycles between January and March 2021 in France.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00784.
    >> Share

  338. KRUSE M, Dark C, Aspden M, Cochrane D, et al
    Performance of the T-SPOT(R).COVID test for detecting SARS-CoV-2-responsive T cells.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00778.
    >> Share

  339. HEYMING TW, Nugent D, Tongol A, Knudsen-Robbins C, et al
    Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00772.
    >> Share

  340. TANAKA H, Lee H, Morita A, Namkoong H, et al
    Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nation-wide Consortium to Investigate Host Genetics of COVID-19.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00775.
    >> Share

  341. MUSA S, Kissling E, Valenciano M, Dizdar F, et al
    Household transmission of SARS-CoV-2: a prospective observational study in Bosnia and Herzegovina, August - December 2020.
    Int J Infect Dis. 2021 Sep 29. pii: S1201-9712(21)00771.
    >> Share

  342. SHINOZUKA J, Hata M, Eguchi H, Mori M, et al
    COVID-19 vaccination: effective utilization of low dead space (LDS) syringes.
    Int J Infect Dis. 2021 Sep 29. pii: S1201-9712(21)00776.
    >> Share

  343. SBERNA G, Basile F, Guarino ML, Capobianchi MR, et al
    Comparison of Allplex SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00781.
    >> Share

  344. NIGO M, Rasmy L, May SB, Rao A, et al
    Real World Long-term Assessment of The Efficacy of Tocilizumab in Patients with COVID19: Results From A Large De-identified Multicenter Electronic Health Record Dataset in the United States.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00774.
    >> Share

  345. HAWLADER MDH, Rahman ML, Nazir A, Ara T, et al
    Belief, Attitude, and Intention to take COVID-19 Vaccine among South Asian Population: A Multi-country Study.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00759.
    >> Share

  346. KARALI EA, Karadenizli A, Uzuner H, Karakaya N, et al
    Comparison of an inactivated Covid19 vaccine-induced antibody response with concurrent natural Covid19 infection.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00768.
    >> Share

  347. SAIA RS, Giusti H, Silva FL, Pedroso KJB, et al
    Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00761.
    >> Share

  348. SAVVA D, Battineni G, Amenta F, Nittari G, et al
    Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2 virus.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00773.
    >> Share

  349. FREMONT-SMITH M, Gherlone N, Smith N, Tisdall P, et al
    Models for COVID-19 Early Cardiac Pathology Following SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 Sep 27. pii: S1201-9712(21)00763.
    >> Share

  350. OYGAR PD, Buyukcam A, Bal ZS, Dalgic N, et al
    SARS-CoV-2 seropositivity among pediatric health care personnel just after the first peak of pandemic: A nationwide surveillance.
    Int J Infect Dis. 2021 Sep 27. pii: S1201-9712(21)00762.
    >> Share

  351. RAVINDRA K, Ahlawat A
    Five probable factors responsible for COVID-associated mucormycosis outbreak in India.
    Int J Infect Dis. 2021 Sep 27. pii: S1201-9712(21)00765.
    >> Share

  352. MARUKI T, Ishikane M, Suzuki T, Ujiie M, et al
    A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient.
    Int J Infect Dis. 2021 Sep 26. pii: S1201-9712(21)00767.
    >> Share

  353. BAMOROVAT M, Sharifi I, Aflatoonian MR, Karamoozian A, et al
    Prophylactic effect of cutaneous leishmaniasis against COVID-19: A case-control field assessment.
    Int J Infect Dis. 2021 Sep 24. pii: S1201-9712(21)00757.
    >> Share

  354. WARSAME A, Bashiir F, Freemantle T, Williams C, et al
    Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Mogadishu, Somalia.
    Int J Infect Dis. 2021 Sep 24. pii: S1201-9712(21)00758.
    >> Share

  355. MORECCHIATO F, Coppi M, Baccani I, Maggini N, et al
    Evaluation of extraction-free RT-PCR methods for faster and cheaper detection of SARS-CoV-2 using two commercial systems.
    Int J Infect Dis. 2021 Sep 23. pii: S1201-9712(21)00754.
    >> Share

  356. BUCHY P, Buisson Y, Cintra O, Dwyer DE, et al
    COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control.
    Int J Infect Dis. 2021 Sep 23. pii: S1201-9712(21)00752.
    >> Share

  357. WEINSTOCK LB, Brook JB, Walters AS, Goris A, et al
    Mast cell activation symptoms are prevalent in Long-COVID.
    Int J Infect Dis. 2021 Sep 23. pii: S1201-9712(21)00751.
    >> Share

  358. BRUNETTI ND, Poliseno M, Bottalico IF, Centola A, et al
    Safety and heart rate changes in Covid-19 patients treated with Remdesivir.
    Int J Infect Dis. 2021 Sep 19. pii: S1201-9712(21)00741.
    >> Share

  359. FINSTERER J
    SARS-CoV-2 in cardiomyocytes.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00737.
    >> Share

  360. EGWANG TG, Owalla TJ, Okurut E, Apungia G, et al
    Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00747.
    >> Share

  361. KHALIFA BA, Abbey EJ, Ayeh SK, Yusuf HE, et al
    The Global Health Security Index is not predictive of vaccine rollout responses among OECD countries.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00744.
    >> Share

  362. BONACCORSI G, Paoli S, Biamonte MA, Moscadelli A, et al
    COVID-19 and schools: what is the risk of contagion? The results of an antigen rapid test-based screening campaign in Florence (Italy).
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00734.
    >> Share

  363. CORREIA AM, Borges V, Isidro J, Lima AR, et al
    Potential recurrence of COVID-19 in a healthcare professional: SARS-CoV-2 genome sequencing confirms contagiousness after re-positivity.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00739.
    >> Share

  364. MORENO A, Vargas C, Azocar F, Villarroel F, et al
    STEROIDS AND MORTALITY IN NON-CRITICALLY ILL COVID-19 PATIENTS: A PROPENSITY SCORE WEIGHTED STUDY IN A CHILEAN COHORT.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00745.
    >> Share

  365. COLANERI M, De Filippo M, Licari A, Marseglia A, et al
    COVID vaccination and asthma exacerbation: might there be a link?
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00733.
    >> Share

  366. DESPHANDE GR, Kaduskar O, Deshpande K, Bhatt V, et al
    Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2.
    Int J Infect Dis. 2021 Sep 17. pii: S1201-9712(21)00732.
    >> Share

  367. LUTALO T, Nalumansi A, Olara D, Kayiwa J, et al
    Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00728.
    >> Share

  368. VACHARATHIT V, Srichatrapimuk S, Manopwisedjaroen S, Kirdlarp S, et al
    SARS-CoV-2 neutralizing antibodies decline after one year and patients with severe COVID-19 pneumonia display a unique cytokine profile.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00729.
    >> Share

  369. BARANDALLA I, Alvarez C, Barreiro P, de Mendoza C, et al
    Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00730.
    >> Share

  370. VON HUTH S, Lillevang ST, Roge BT, Madsen JS, et al
    SARS-CoV-2 seroprevalence among 7,950 health-care workers in the Region of Southern Denmark. (THEIJID-D-21-01420R1).
    Int J Infect Dis. 2021 Sep 14. pii: S1201-9712(21)00731.
    >> Share

  371. HASAN MR, Kalikiri MKR, Mirza F, Sundararaju S, et al
    Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar.
    Int J Infect Dis. 2021 Sep 12. pii: S1201-9712(21)00709.
    >> Share

  372. ZHAO Y, Yang C, An X, Xiong Y, et al
    Follow-up study on the COVID-19 survivors after one year discharged from hospital.
    Int J Infect Dis. 2021 Sep 11. pii: S1201-9712(21)00726.
    >> Share

  373. ELOY P, Tardivon C, Martin-Blondel G, Isnard M, et al
    Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00724.
    >> Share

  374. ZHOU D, Wang Q, Liu H
    Coronavirus disease-19 and the gut-lung axis.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00722.
    >> Share

  375. LEINER J, Pellissier V, Nitsche A, Konig S, et al
    SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00717.
    >> Share

  376. HARA H, Uemura Y, Hayakawa K, Togano T, et al
    Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00725.
    >> Share

  377. LOBIE TA, Roba AA, Booth JA, Kristiansen KI, et al
    Antimicrobial resistance: A challenge awaiting the post COVID-19 era.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00708.
    >> Share

  378. GOLDIN L, Elders T, Werhane L, Korwek K, et al
    Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00713.
    >> Share

  379. BYLICKI O, Delarbre D, Mayet A, Ferrier A, et al
    Neutralizing antibodies response to SARS-CoV-2 are persistent 9 months post symptom onset in mild or asymptomatic patients.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00707.
    >> Share

  380. SATO K, Mano T, Niimi Y, Toda T, et al
    Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of self-reporting database.
    Int J Infect Dis. 2021 Sep 4. pii: S1201-9712(21)00704.
    >> Share

  381. LOUCA S
    SARS-CoV-2 infections in 165 countries over time.
    Int J Infect Dis. 2021 Sep 3. pii: S1201-9712(21)00701.
    >> Share

  382. VICENTI I, Basso M, Gatti F, Scaggiante R, et al
    Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose.
    Int J Infect Dis. 2021 Sep 2. pii: S1201-9712(21)00683.
    >> Share

  383. NGERE I, Dawa J, Hunsperger E, Otieno N, et al
    sssHigh seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
    Int J Infect Dis. 2021 Sep 2. pii: S1201-9712(21)00696.
    >> Share

    August 2021
  384. DE GUADIANA-ROMUALDO LG, Martinez MM, Mulero MDR, Torrella PE, et al
    Circulating MR-proADM levels, as indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients.
    Int J Infect Dis. 2021 Aug 27. pii: S1201-9712(21)00692.
    >> Share

  385. SALVAGNO GL, Henry BM, Lippi G
    The strength of association between pre- and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay.
    Int J Infect Dis. 2021 Aug 26. pii: S1201-9712(21)00693.
    >> Share

  386. DIRKX KKT, Mulder B, Post AS, Rutten MH, et al
    The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
    Int J Infect Dis. 2021 Aug 26. pii: S1201-9712(21)00691.
    >> Share

  387. CHEN Y, Yao H, Fu J, Shu Q, et al
    The low contagiousness and new A958D mutation of SARS-CoV-2 in children: An observational cohort study.
    Int J Infect Dis. 2021 Aug 25. pii: S1201-9712(21)00672.
    >> Share

  388. POUR OB, Yahyavi Y, Karimi A, Khamaneh AM, et al
    Serum trace elements levels and clinical outcomes among Iranian COVID-19 patients.
    Int J Infect Dis. 2021 Aug 25. pii: S1201-9712(21)00686.
    >> Share

  389. BHANUPRASAD K, Manesh A, Devasagayam E, Varghese L, et al
    Risk Factors Associated with the Mucormycosis Epidemic During the COVID-19 Pandemic.
    Int J Infect Dis. 2021 Aug 24. pii: S1201-9712(21)00670.
    >> Share

  390. VAN DAM CS, Lede I, Schaar J, Al-Dulaimy M, et al
    Herpes Zoster after COVID-vaccination.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00681.
    >> Share

  391. VAN HEERDEN J, Nel J, Moodley P, Govender P, et al
    Multisystem Inflammatory Syndrome (MIS): a multicentre retrospective review of adults and adolescents in South Africa.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00673.
    >> Share

  392. YANG J, Han Y, Zhang R, Zhang R, et al
    Comparison of analytical sensitivity of SARS-CoV-2 molecular detection kits.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00676.
    >> Share

  393. L SBB, Wanve S, Koradia P, Bhomia V, et al
    Efficacy and Safety of Pegylated Interferon-alpha2b in Moderate COVID-19: A phase 3, randomized, comparator-controlled, open-label study.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00677.
    >> Share

  394. MOUALLEM RE, Moussally K, Williams A, Repetto E, et al
    How COVID-19 highlighted the need for infection prevention and control measures to become central to the global conversation: experience from the conflict settings of the Middle-East.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00668.
    >> Share

  395. TIMELLI L, Liuzzi G, Cannavacciuolo A, Petrosillo N, et al
    Association of COVID-19 case-fatality rate with disease burden: an ecological analysis in Italy during the first wave.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00665.
    >> Share

  396. GONG C, Song X, Li X, Lu L, et al
    Immunological Changes after COVID-19 Vaccination in an HIV-Positive Patient.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00667.
    >> Share

  397. VELAVAN T, Pallerla S, Kremsner P
    How to ab(use) a COVID-19 antigen rapid test with soft drinks?
    Int J Infect Dis. 2021 Aug 18. pii: S1201-9712(21)00654.
    >> Share

  398. CUI LY, Cheng WW, Mou ZW, Xiao D, et al
    Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis.
    Int J Infect Dis. 2021 Aug 18. pii: S1201-9712(21)00649.
    >> Share

  399. ELMOHEEN A, Abdelhafez I, Awad W, Bahgat M, et al
    External Validation and Recalibration of the CURB-65 and PSI for Predicting 30-Day Mortality and Critical Care Intervention in Multiethnic Patients with COVID-19.
    Int J Infect Dis. 2021 Aug 17. pii: S1201-9712(21)00660.
    >> Share

  400. PASQUINI Z, Barocci I, Brescini L, Candelaresi B, et al
    Bloodstream infections in the COVID-19 era: results from an Italian multicenter study.
    Int J Infect Dis. 2021 Aug 17. pii: S1201-9712(21)00623.
    >> Share

  401. DARBANDI A, Asadi A, Ghanavati R, Afifirad R, et al
    Corrigendum to 'The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010-20' [International Journal of Infectious Diseases 105 (April 2021) 91-104].
    Int J Infect Dis. 2021;110:337.
    >> Share

  402. TADESSE EB, Endris AA, Solomon H, Alayu M, et al
    Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020.
    Int J Infect Dis. 2021 Aug 16. pii: S1201-9712(21)00661.
    >> Share

  403. IMAI K, Matsuoka M, Tabata S, Kitagawa Y, et al
    Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severity.
    Int J Infect Dis. 2021 Aug 15. pii: S1201-9712(21)00659.
    >> Share

  404. WRIGHT J, Achana F, Diwakar L, Semple MG, et al
    Cycle threshold values are inversely associated with poorer outcomes in hospitalised patients with Covid-19: a prospective, observational cohort study conducted at a UK tertiary hospital.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00657.
    >> Share

  405. SELINGER C, Choisy M, Alizon S
    Predicting COVID-19 incidence in French hospitals using human contact network analytics.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00662.
    >> Share

  406. BIRKHEAD M, Glass AJ, Allan-Gould H, Goossens C, et al
    Ultrastructural evidence for vertical transmission of SARS-CoV2.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00653.
    >> Share

  407. LIANG L, Guo Q, Zhang H, Lin S, et al
    Low infectious risk of re-positive COVID-19 patients: a single-center study.
    Int J Infect Dis. 2021 Aug 12. pii: S1201-9712(21)00652.
    >> Share

  408. KEITOKU K, Nishimura Y, Hagiya H, Koyama T, et al
    Impact of the World Antimicrobial Awareness Week on public interest between 2015 and 2020: A Google Trends analysis.
    Int J Infect Dis. 2021 Aug 12. pii: S1201-9712(21)00651.
    >> Share

  409. MARRA V, Quartin M
    A Bayesian estimate of the early COVID-19 infection fatality ratio in Brazil based on a random seroprevalence survey.
    Int J Infect Dis. 2021 Aug 11. pii: S1201-9712(21)00648.
    >> Share

  410. NONAKA CKV, Graf T, Barcia CAL, Costa VF, et al
    SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, northeast Brazil, February 2021.
    Int J Infect Dis. 2021 Aug 11. pii: S1201-9712(21)00635.
    >> Share

  411. SAEED BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, et al
    Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination.
    Int J Infect Dis. 2021 Aug 9. pii: S1201-9712(21)00646.
    >> Share

  412. NAKAMURA Y, Katano H, Nakajima N, Sato Y, et al
    SARS-CoV-2 is localized in cardiomyocytes: a post-mortem biopsy case.
    Int J Infect Dis. 2021 Aug 9. pii: S1201-9712(21)00647.
    >> Share

  413. JACOB L, Koyanagi A, Smith L, Haro JM, et al
    Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021.
    Int J Infect Dis. 2021 Aug 8. pii: S1201-9712(21)00642.
    >> Share

  414. BUTT AA, Nafady-Hego H, Chemaitelly H, Abou-Samra AB, et al
    Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination: Breakthrough SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00639.
    >> Share

  415. PIMENOFF VN, Bjornstedt M, Dillner J
    Severe features during outbreak but low mortality observed immediately before and after a March-May Covid-19 outbreak in Stockholm, Sweden.: Mortality before, during and after a COVID-19 outbreak.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00637.
    >> Share

  416. DIAZ-AROCUTIPA C, Melgar-Talavera B, Alvarado-Yarasca A, Saravia-Bartra MM, et al
    Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147,824 patients.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00636.
    >> Share

  417. THANGARAJU P, B AK, Venkatesan S
    Vigilance in selection of low-dose versus high-dose steroids in COVID-19.
    Int J Infect Dis. 2021;109:54-55.
    >> Share

    July 2021
  418. CLARO F, Silva D, Rodriguez M, Rangel R, et al
    IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose.
    Int J Infect Dis. 2021 Jul 31. pii: S1201-9712(21)00626.
    >> Share

  419. CHAU NVV, Nhan LNT, Nguyet LA, Tu NTK, et al
    Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam.
    Int J Infect Dis. 2021 Jul 30. pii: S1201-9712(21)00629.
    >> Share

  420. PATINO LH, Ballesteros N, Munoz M, Castaneda S, et al
    SARS-CoV-2 in transit: characterization of SARS-CoV-2 genomes from Venezuelan migrants in Colombia.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00624.
    >> Share

  421. YARANAGULA SD, Koduri VKC
    DimachkieSpectrum of Acute Neuropathy Associated with Covid-19: Clinical and electrophysiological study of 13 patients from a single center.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00621.
    >> Share

  422. AMIR M, Yoseph H, Farisi ATA, Phie JKP, et al
    Symptomatic Bradycardia in Covid-19 Hospitalized Patients: a Case Series.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00625.
    >> Share

  423. CHEN YH, Fang CT, Huang YL
    Effect of Non-lockdown Social Distancing and Testing-Contact Tracing During a COVID-19 Outbreak in Daegu, South Korea, February to April 2020: A Modeling Study.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00614.
    >> Share

  424. VELASQUEZ SR, Jacques L, Dalal J, Sestito P, et al
    The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00616.
    >> Share

  425. PALOMBA E, Carrabba M, Zuglian G, Alagna L, et al
    Treatment of SARS-CoV-2 Relapse with Remdesivir and Neutralizing Antibodies Cocktail in a Patient with X-Linked Agammaglobulinemia.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00619.
    >> Share

  426. PERKMANN T, Perkmann-Nagele N, Mucher P, Radakovics A, et al
    Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00620.
    >> Share

  427. QUACH HL, Nguyen KC, Hoang NA, Pham TQ, et al
    Association of public health interventions and COVID-19 incidence in Vietnam, January to December 2020.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00600.
    >> Share

  428. ZANDI M, Behboudi E, Soltani S
    Can seasonal influenza vaccine for 2019/2020 has cross reactivity with some of SARS-CoV-2 proteins?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00611.
    >> Share

  429. PAUL E, Brown GW, Dechamps M, Kalk A, et al
    Covid-19: An extra-terrestrial disease?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00609.
    >> Share

  430. ILIC I, Stojanovic DU, Loncar G
    Influenza immunization and COVID-19 - can viral structure be responsible for the effect?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00610.
    >> Share

  431. AHMED S, Khan WA
    A Five-day Course of Ivermectin may Reduce the Duration of COVID-19 Illness.
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00606.
    >> Share

  432. ALBAHRANI S, AlBarraK A, Alghamdi OA, Abdullah Alghamdi M, et al
    Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 vaccine in Vaccinee in Saudi Arabia.
    Int J Infect Dis. 2021 Jul 25. pii: S1201-9712(21)00608.
    >> Share

  433. BROTONS P, Perez-Arguello A, Launes C, Torrents F, et al
    Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples.
    Int J Infect Dis. 2021 Jul 25. pii: S1201-9712(21)00607.
    >> Share

  434. MARCOLINO MS, Pires MC, Ramos LEF, Silva RT, et al
    ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores.
    Int J Infect Dis. 2021 Jul 23. pii: S1201-9712(21)00605.
    >> Share

  435. GORDON PDMMV, McCarthy PDKA, Proctor PDJL, Hagedorn MBL, et al
    Evaluating COVID-19 reporting data in the context of testing strategies across 31 LMICs.
    Int J Infect Dis. 2021 Jul 22. pii: S1201-9712(21)00599.
    >> Share

  436. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
    BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00598.
    >> Share

  437. SIRIPURAPU G, Samad SA, Fatima S, Wig N, et al
    SUCCESSFUL MANAGEMENT OF POST-COVID-19 ACANTHAMOEBIC ENCEPHALITIS.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00602.
    >> Share

  438. GERTLER M, Krause E, van Loon W, Krug N, et al
    Self-collected oral, nasal and saliva samples yield sensitivity comparable to professional-collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis among symptomatic outpatients.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00601.
    >> Share

  439. LELI C, Matteo LD, Gotta F, Cornaglia E, et al
    Performance of a SARS CoV-2 antigen rapid immunoassay in patients admitted to the Emergency Department.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00597.
    >> Share

  440. OKPALA OV, Dim CC, Ugwu CI, Onyemaechi S, et al
    Population seroprevalence of SARS-CoV-2 antibodies in Anambra state, South-East, Nigeria.
    Int J Infect Dis. 2021 Jul 19. pii: S1201-9712(21)00596.
    >> Share

  441. ALSHUKAIRI AN, El-Kafrawy SA, Dada A, Yasir M, et al
    Re-infection with different SARS-CoV-2 clade and prolonged viral shedding in a patient with hematopoietic stem cell transplantation: SARS-CoV-2 Re-infection with different clade.
    Int J Infect Dis. 2021 Jul 18. pii: S1201-9712(21)00592.
    >> Share

  442. RENISI G, Lombardi A, Massimo S, Alessandro I, et al
    ANTERIOR UVEITIS ONSET AFTER BNT162b2 VACCINATION: IS THIS JUST A COINCIDENCE?
    Int J Infect Dis. 2021 Jul 18. pii: S1201-9712(21)00591.
    >> Share

  443. LALWANI P, Salgado BB, Filho IVP, da Silva DSS, et al
    SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00576.
    >> Share

  444. ALKOFIDE H, Almohaizeie A, Almuhaini S, Alotaibi B, et al
    Tocilizumab and Systemic Corticosteroids in the Management of COVID-19 Patients:A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00578.
    >> Share

  445. HUSNAYAIN A, Chuang TW, Fuad A, Su EC, et al
    High variability in model performance of Google relative search volume in spatially clustered COVID-19 areas of the United States.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00587.
    >> Share

  446. YAMAGUCHI T, Shinagawa T, Kobata H, Nakagawa H, et al
    Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00571.
    >> Share

  447. MARKEWITZ R, Torge A, Wandinger KP, Pauli D, et al
    Analysis of SARS-CoV-2 RT-qPCR Ct values vis-a-vis anti-SARS-CoV-2 antibodies from a high incidence region.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00570.
    >> Share

  448. DARCIS G, Bouquegneau A, Maes N, Thys M, et al
    Long-term clinical follow up of patients suffering from moderate to severe COVID-19 infection: A monocentric prospective observational cohort study.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00572.
    >> Share

  449. TONIASSOA SCC, Fernandesa FS, Jovelevithsb D, Filhoc FFD, et al
    Reduction in COVID-19 prevalence in health care workers in a university hospital in southern Brazil after the start of vaccination.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00582.
    >> Share

  450. CONNOR BA, Couto-Rodriguez M, Barrows JE, Gardner M, et al
    Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00586.
    >> Share

  451. IRWIN N, Murray L, Ozynski B, Richards GA, et al
    nnAge significantly influences the sensitivity of SARS-CoV-2 rapid antibody assays.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00585.
    >> Share

  452. NUNEZ-ZAPATA SF, Benites-Peralta B, Mayta-Tristan P, Rodriguez-Morales AJ, et al
    High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for heard immunity!
    Int J Infect Dis. 2021 Jul 11. pii: S1201-9712(21)00579.
    >> Share

  453. KIM JH, Roh YH, Ahn JG, Kim MY, et al
    Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19.
    Int J Infect Dis. 2021 Jul 7. pii: S1201-9712(21)00560.
    >> Share

  454. MALIK M, Kunze AC, Bahmer T, Herget-Rosenthal S, et al
    SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00567.
    >> Share

  455. SOLDEVILA L, Valerio-Sallent L, Roure S, Perez-Quilez O, et al
    Drug exposure may have a substantial influence on COVID-19 prognosis among residents of long-term care facilities: an exploratory analysis.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00562.
    >> Share

  456. ALSHAMRANI MM, El-Saed A, Zunitan MA, Almulhem R, et al
    Risk of COVID-19 morbidity and mortality among healthcare workers working in a Large Tertiary Care Hospital.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00564.
    >> Share

  457. ELHARAKE JA, Galal B, Alqahtani SA, Kattan RF, et al
    COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00559.
    >> Share

  458. JEGERLEHNER S, Suter-Riniker F, Jent P, Bittel P, et al
    Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00565.
    >> Share

  459. ROVIDA F, Cassaniti I, Percivalle E, Sarasini A, et al
    Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-control study.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00558.
    >> Share

  460. MUCHELENG'ANGA LA, Telendiy V, Hamukale A, Shibemba AL, et al
    COVID-19 and Sudden Unexpected Community Deaths in Lusaka, Zambia, Africa - A Medico-Legal Whole-Body Autopsy Case Series.
    Int J Infect Dis. 2021;109:160-167.
    >> Share

  461. JACOB L, Koyanagi A, Smith L, Tanislav C, et al
    Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.
    Int J Infect Dis. 2021 Jul 2. pii: S1201-9712(21)00552.
    >> Share

    June 2021
  462. FERGUSON J, Murugesan K, Banaei N, Liu A, et al
    Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00542.
    >> Share

  463. W T, A A, A T, V V, et al
    Evaluation of potassium peroxymonosulfate (MPS) efficacy against SARS-CoV-2 virus using RT-qPCR-based method.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00545.
    >> Share

  464. BALUSHI AA, AlShekaili J, Kindi MA, Ansari Z, et al
    Immunological predictors of disease severity in patients with COVID-19.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00546.
    >> Share

  465. HSU SH, Chang SH, Gross C, Wang SY, et al
    Relative risks of Covid-19 fatality between the first and second waves of the pandemic in Ontario, Canada.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00548.
    >> Share

  466. BUNDGAARD JS, Raaschou-Pedersen DT, Todsen T, Ringgaard A, et al
    Danish Citizen s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00550.
    >> Share

  467. LASTRUCCI V, Bonaccorsi G, Forni S, D'Arienzo S, et al
    The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00547.
    >> Share

  468. PANDIT A, Bhalani N, Bhushan BLS, Koradia P, et al
    Corrigendum to "Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].
    Int J Infect Dis. 2021 Jun 27. pii: S1201-9712(21)00519.
    >> Share

  469. WIBOWO A, Pranata R, Lim MA, Akbar MR, et al
    Endotheliopathy Marked by High von Willebrand Factor (vWF) Antigen in COVID-19 is Associated with Poor Outcome: A Systematic Review and Meta-analysis.
    Int J Infect Dis. 2021 Jun 27. pii: S1201-9712(21)00540.
    >> Share

  470. KUMAR SHUKLA DA, Misra DS
    Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible.
    Int J Infect Dis. 2021 Jun 24. pii: S1201-9712(21)00535.
    >> Share

  471. SPEECKAERT MM, Delanghe JR
    The potential significance of vitamin D binding protein polymorphism in COVID-19.
    Int J Infect Dis. 2021 Jun 23. pii: S1201-9712(21)00532.
    >> Share

  472. YAMAMOTO K, Suzuki M, Yamada G, Sudo T, et al
    Corrigendum to "Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission" [Int J Infect Dis 104 (2021) 65-72].
    Int J Infect Dis. 2021 Jun 22. pii: S1201-9712(21)00498.
    >> Share

  473. BRUNO A, de Mora D, Freire-Paspuel B, Rodriguez AS, et al
    Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.
    Int J Infect Dis. 2021 Jun 21. pii: S1201-9712(21)00526.
    >> Share

  474. KAMALADASA A, Gunasekara B, Jeewandara C, Jayathilaka D, et al
    Comparison of two assays to detect IgG antibodies to the receptor binding domain of the SARSCoV2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.
    Int J Infect Dis. 2021 Jun 20. pii: S1201-9712(21)00520.
    >> Share

  475. ALHINAI ZA, Elsidig N
    Countries with similar Covid-19 vaccination rates yet divergent outcomes: are all vaccines created equal?
    Int J Infect Dis. 2021 Jun 19. pii: S1201-9712(21)00527.
    >> Share

  476. FW H, Tc L, Dt A, R L, et al
    Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomised controlled trial.
    Int J Infect Dis. 2021 Jun 19. pii: S1201-9712(21)00523.
    >> Share

  477. TANISALI G, Sozak A, Bulut AS, Sander TZ, et al
    Effectiveness of different types of Masks in Aerosol Dispersion in SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 Jun 17. pii: S1201-9712(21)00518.
    >> Share

  478. DUARTE CM, Jamil T, Gojobori T, Alam I, et al
    Detection of SARS-CoV-2 variants requires urgent global coordination.
    Int J Infect Dis. 2021 Jun 17. pii: S1201-9712(21)00516.
    >> Share

  479. HIMWAZE CM, Telendiy V, Maate F, Mupeta S, et al
    Post-mortem examination of Hospital Inpatient COVID-19 Deaths in Lusaka, Zambia - A Descriptive Whole-body Autopsy Series.
    Int J Infect Dis. 2021;108:363-369.
    >> Share

  480. SONG G, Qiao W, Wang X, Yu X, et al
    Association of lung ultrasound score with mortality and severity of COVID-19: A Meta-analysis and Trial Sequential Analysis.
    Int J Infect Dis. 2021 Jun 16. pii: S1201-9712(21)00513.
    >> Share

  481. AKHMETZHANOV AR, Jung SM, Cheng HY, Thompson RN, et al
    A hospital-related outbreak of SARS-CoV-2 associated with a novel variant Cal.20C (B.1.429) in Taiwan: transmission potential and outbreak containment under intensified contact tracing, January-February 2021.
    Int J Infect Dis. 2021 Jun 16. pii: S1201-9712(21)00517.
    >> Share

  482. HANS L, Steegen K, Ketseoglou I, Mahlumba Z, et al
    Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00508.
    >> Share

  483. MONEDERO-RECUERO I, Gegia M, Wares DF, S Chadha S, et al
    Situational analysis of the 10 high drug resistant tuberculosis burden countries two years post-UNHLM declaration: progress and setbacks in a changing landscape.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00511.
    >> Share

  484. BOOGAARD LH, Sikkema RS, van Beek J, Brockhoff HJ, et al
    A mixed methods approach to elucidate SARS-CoV-2 transmission routes and clustering in outbreaks in native workers and labour migrants in the fruit and vegetable packaging industry in South Holland, the Netherlands, May to July 2020.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00510.
    >> Share

  485. KASPERSEN KA, Greve T, Nielsen KJ, Jespersen S, et al
    Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020.
    Int J Infect Dis. 2021 Jun 11. pii: S1201-9712(21)00506.
    >> Share

  486. GUZMAN NA, De la Hoz Restrepo F, Serrano-Coll H, Gastelbondo B, et al
    Using serological studies to assess COVID-19 infection fatality rate in developing countries. A case study from one Colombian department.
    Int J Infect Dis. 2021 Jun 11. pii: S1201-9712(21)00507.
    >> Share

  487. VALLEJO-JANETA AP, Morales-Jadan D, Freire-Paspuel B, Lozada T, et al
    COVID-19 outbreaks at shelters for women victims of gender-based violence from Ecuador.
    Int J Infect Dis. 2021 Jun 10. pii: S1201-9712(21)00501.
    >> Share

  488. MEDINA N, Alastruey-Izquierdo A, Bonilla O, Ortiz B, et al
    Impact of the COVID-19 pandemic on HIV care in Guatemala.
    Int J Infect Dis. 2021 Jun 10. pii: S1201-9712(21)00500.
    >> Share

  489. PORTO MH, Castro B, Diaz Z, Pedroso Y, et al
    SARS-CoV-2 infection in properly vaccinated healthcare workers.
    Int J Infect Dis. 2021 Jun 9. pii: S1201-9712(21)00499.
    >> Share

  490. DIAZ Y, Ortiz A, Weeden A, Castillo D, et al
    SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama.
    Int J Infect Dis. 2021 Jun 6. pii: S1201-9712(21)00493.
    >> Share

  491. CHEN S, Zheng T, Wang S, Yu Y, et al
    Association between risk of VTE and mortality in patients with COVID-19.
    Int J Infect Dis. 2021 Jun 6. pii: S1201-9712(21)00494.
    >> Share

  492. YEN MY, Yen YF, Chen SY, Lee TI, et al
    Learning from the past: Taiwan's responses to COVID-19 versus SARS.
    Int J Infect Dis. 2021 Jun 4. pii: S1201-9712(21)00490.
    >> Share

  493. LI X, Yin Y, Pang L, Xu S, et al
    Colloidal gold immunochromatographic assay (GICA) is an effective screening method for identifying detectable anti-SARS-CoV-2 neutralizing antibodies.
    Int J Infect Dis. 2021 Jun 3. pii: S1201-9712(21)00484.
    >> Share

  494. MAYANSKIY N, Brzhozovskaya E, Fedorova N, Lebedin Y, et al
    Parallel detection of SARS-CoV-2 RNA and nucleocapsid antigen in nasopharyngeal specimens from a COVID-19 patient screening cohort.
    Int J Infect Dis. 2021 Jun 3. pii: S1201-9712(21)00486.
    >> Share

  495. KINOSHITA M, Sato K, Vellingiri B, Green SJ, et al
    Inverse association between hypertension treatment and COVID-19 prevalence in Japan.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00474.
    >> Share

  496. TOCZYLOWSKI K, Jackowska K, Lewandowski D, Kurylonek S, et al
    Rotavirus gastroenteritis in children hospitalized in northeastern Poland in 2006-2020: severity, seasonal trends, and impact of immunization.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00473.
    >> Share

  497. MOLINA GA, Ayala AV, Endara SA, Aguayo WG, et al
    Ecuador and Covid-19, A Pandemic we won't be able to run away from.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00480.
    >> Share

  498. GREUEL S, Ihlow J, Dragomir MP, Streit S, et al
    COVID-19: Autopsy findings in six patients between 26 and 46 years of age.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00472.
    >> Share

  499. PETERSEN E, Schlagenhauf P, Lee SS, Blumberg L, et al
    Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics.
    Int J Infect Dis. 2021;108:156-158.
    >> Share

  500. RAGHAV K, Anand S, Gothwal A, Singh P, et al
    Underreporting of race/ethnicity in COVID-19 research.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00479.
    >> Share

  501. CAMELENA F, Poncin T, Dudoignon E, Salmona M, et al
    rcent agreement; NPA: negative percent agreeRapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00477.
    >> Share

  502. LEIXNER G, Voill-Glaninger A, Bonner E, Kreil A, et al
    Evaluation of the AMP SARS-CoV-2 Rapid Antigen Test in a Hospital Setting.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00466.
    >> Share

  503. NG DC, Tan KK, Ling C, Ali MM, et al
    Clinical and epidemiological characteristics of children with COVID-19 in Negeri Sembilan, Malaysia.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00476.
    >> Share

  504. KAMSTRUP P, Sivapalan P, Eklof J, Hoyer N, et al
    Hydroxychloroquine as a primary prophylactic agent against sars-cov-2 infection: a cohort study.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00478.
    >> Share

    May 2021
  505. HIROTSU Y, Sugiura H, Maejima M, Hayakawa M, et al
    Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
    Int J Infect Dis. 2021 May 31. pii: S1201-9712(21)00470.
    >> Share

  506. LIM AY, Cheong HK, Oh YJ, Lee JK, et al
    Modeling the early temporal dynamics of viral load in respiratory tract specimens of COVID-19 patients in Incheon, the Republic of Korea.
    Int J Infect Dis. 2021 May 28. pii: S1201-9712(21)00465.
    >> Share

  507. YOUSEFINAGHANI S, Dara R, Mubareka S, Papadopoulos A, et al
    An Analysis of COVID-19 Vaccine Sentiments and Opinions on Twitter.
    Int J Infect Dis. 2021 May 27. pii: S1201-9712(21)00462.
    >> Share

  508. PAGNESI M, Inciardi RM, Lombardi CM, Agostoni P, et al
    Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study.
    Int J Infect Dis. 2021 May 27. pii: S1201-9712(21)00458.
    >> Share

  509. UMEMURA Y, Mitsuyama Y, Minami K, Nishida T, et al
    Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by Coronavirus disease 2019: An interventional study.
    Int J Infect Dis. 2021 May 25. pii: S1201-9712(21)00456.
    >> Share

  510. ARMINANZAS C, Arnaiz de Las Revillas F, Gutierrez Cuadra M, Arnaiz A, et al
    USEFULNESS OF THE COVID-GRAM AND CURB-65 SCORES FOR PREDICTING SEVERITY IN PATIENTS WITH COVID-19.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00450.
    >> Share

  511. RUBIO CP, Franco-Martinez L, Resalt CS, Torres-Cantero A, et al
    Evaluation of different sample treatments options in a simple and safe procedure for the detection of SARS-COV-2 in saliva.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00455.
    >> Share

  512. LEE H, Noh E, Jeon H, Nam EW, et al
    Association between the traffic level from other areas and the COVID-19 prevalence at the provincial levels in South Korea.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00457.
    >> Share

  513. AHMAD F, Ahmed A, Rajendraprasad SS, Loranger A, et al
    Multisystem Inflammatory Syndrome in Adults: A Rare Sequela of SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00452.
    >> Share

  514. LUKITO AA, Widysanto A, Lemuel TAY, Prasetya IB, et al
    Candesartan as a tentative treatment for COVID-19: a prospective non-randomized open-label study.
    Int J Infect Dis. 2021 May 23. pii: S1201-9712(21)00420.
    >> Share

  515. NAGANO H, Takada D, Shin JH, Morishita T, et al
    Corrigendum to 'Hospitalization of mild cases of community-acquired pneumonia decreased more than severe cases during the COVID-19 pandemic.' [Int J Infect Dise. Vol 106 (2021) P323-328].
    Int J Infect Dis. 2021;107:254.
    >> Share

  516. BABU GR, Sundaresan R, Athreya S, Akhtar J, et al
    The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India.
    Int J Infect Dis. 2021 May 21. pii: S1201-9712(21)00445.
    >> Share

  517. CAMICI M, Zuppi P, Lorenzini P, Scarnecchia L, et al
    The role of testosterone in SARS-CoV-2 infection: a key pathogenic factor and a biomarker for severe pneumonia.
    Int J Infect Dis. 2021 May 20. pii: S1201-9712(21)00444.
    >> Share

  518. MURHEKAR MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, et al
    SARS-CoV-2 sero-prevalence among general population and healthcare workers in India, December 2020 - January 2021.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00442.
    >> Share

  519. NIELSEN KJ, Vestergaard JM, Schlunssen V, Bonde JP, et al
    Day by day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalised health-care workers: a 90-day follow-up study.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00434.
    >> Share

  520. KIM J, Gomez REG, Hong K, Yum S, et al
    The changing influenza activity in the Southern hemisphere countries during the COVID-19 pandemic.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00441.
    >> Share

  521. RAY JG, Colacci M, Schull MJ, Vermeulen MJ, et al
    Non-ABO red cell antibodies and risk of COVID-19.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00440.
    >> Share

  522. FAY FF, Alvarez-Moreno CA, Bonvehi PE, Espinoza CC, et al
    A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00412.
    >> Share

  523. HAMMER CC, Boender TS, Thomas DR
    Social media for field epidemiologists (#SoMe4epis): How to use Twitter during the #COVID19 pandemic.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00437.
    >> Share

  524. SASIKALA M, Shashidhar J, Deepika G, Ravikanth V, et al
    Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00436.
    >> Share

  525. VICENTI I, Gatti F, Scaggiante R, Boccuto A, et al
    Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00435.
    >> Share

  526. HAYER J, Kasapic D, Zemmrich C
    Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020.
    Int J Infect Dis. 2021 May 17. pii: S1201-9712(21)00431.
    >> Share

  527. ALSHUKAIRI AN, Tolah AM, Dada A, Al-Tawfiq JA, et al
    Test-based De-isolation in COVID-19 Immunocompromised patients: Ct value versus SARS-CoV-2 viral cultures.
    Int J Infect Dis. 2021 May 15. pii: S1201-9712(21)00429.
    >> Share

  528. FATTEH N, Sutherland GE, Santos RG, Zeidan R, et al
    Association of Hypothermia with Increased Mortality Rate in SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 May 15. pii: S1201-9712(21)00433.
    >> Share

  529. MUMOLI N, Evangelista I, Colombo A, Conte G, et al
    Transient perivascular inflammation of the carotid artery (TIPIC) syndrome in a patient with COVID-19.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00418.
    >> Share

  530. JASPARD M, Sow MS, Juchet S, Diendere E, et al
    Clinical presentation, outcomes and factors associated with mortality: a prospective study from three COVID-19 referral care centers in West Africa.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00425.
    >> Share

  531. MARTHA JW, Pranata R, Lim MA, Wibowo A, et al
    Active Prescription of Low-dose Aspirin During or Prior to Hospitalization and Mortality in COVID-19 - A Systematic Review and Meta-analysis of Adjusted Effect Estimates.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00417.
    >> Share

  532. ZAQOUT A, Daghfal J, Alaqad I, Hussein SAN, et al
    The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.
    Int J Infect Dis. 2021 May 13. pii: S1201-9712(21)00422.
    >> Share

  533. CUCUNAWANGSIH C, Wijaya RS, Lugito NPH, Suriapranata I, et al
    Post-vaccination COVID-19 cases among healthcare workers at Siloam Teaching Hospital, Indonesia.
    Int J Infect Dis. 2021 May 13. pii: S1201-9712(21)00421.
    >> Share

  534. SMAGHI BS, Collins J, Dagina R, Hiawalyer G, et al
    Barriers and enablers experienced by health care workers in swabbing for COVID-19 in Papua New Guinea: a multi-methods cross-sectional study, November - December 2020.
    Int J Infect Dis. 2021 May 12. pii: S1201-9712(21)00390.
    >> Share

  535. DE SIQUEIRA IC, Camelier AA, Maciel EAP, Nonaka CKV, et al
    Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil.
    Int J Infect Dis. 2021 May 11. pii: S1201-9712(21)00411.
    >> Share

  536. WANNIGAMA DL, Amarasiri M, Hurst C, Phattharapornjaroen P, et al
    Tracking COVID-19 with wastewater to understand asymptomatic transmission.
    Int J Infect Dis. 2021 May 11. pii: S1201-9712(21)00406.
    >> Share

  537. WU J, Chen X, Gong L, Huo S, et al
    Epidemiological and clinical features of SARS-CoV-2 cluster infection in Anhui Province, Eastern China.
    Int J Infect Dis. 2021 May 10. pii: S1201-9712(21)00376.
    >> Share

  538. ZHANG X, Jiang M, Yang J
    Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19.
    Int J Infect Dis. 2021 May 6. pii: S1201-9712(21)00402.
    >> Share

  539. SUZUKI T, Kutsuna S, Saito S, Kawashima A, et al
    Clinical course of alopecia after severe acute respiratory syndrome coronavirus 2 infection.
    Int J Infect Dis. 2021 May 4. pii: S1201-9712(21)00400.
    >> Share

  540. BEZERRA ALVES JG, Natal Figueiroa J, Urquia ML
    Impact of COVID-19 on immunization of Brazilian infants.
    Int J Infect Dis. 2021 May 4. pii: S1201-9712(21)00401.
    >> Share

  541. PENA M, Ampuero M, Garces C, Gaggero A, et al
    Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals.
    Int J Infect Dis. 2021 May 1. pii: S1201-9712(21)00399.
    >> Share

  542. CAVALCANTE PINTO V JUNIOR, Moura LFWG, Cavalcante RC, Rubens Costa Lima J, et al
    Prevalence of COVID-19 in children, adolescents, and adults in remote education situation in the city of Fortaleza - Brazil.
    Int J Infect Dis. 2021 May 1. pii: S1201-9712(21)00398.
    >> Share

  543. HAUSDORFF WP, Flores J
    Hausdorff and Flores Author Reply to Letter to the Editor by Prof G. Bauer (THEIJID-D-21-00652).
    Int J Infect Dis. 2021;106:78.
    >> Share

  544. BONILLA-ALDANA DK, Jimenez-Diaz SD, Arango-Duque JS, Aguirre-Florez M, et al
    Reply to "Misconceptions and misinformation about bats and viruses".
    Int J Infect Dis. 2021;106:197-198.
    >> Share

    April 2021
  545. NASIRI M, Khodadadi J, Molaei S
    Does vitamin D serum level affect prognosis of COVID-19 patients?
    Int J Infect Dis. 2021 Apr 30. pii: S1201-9712(21)00395.
    >> Share

  546. PETERSEN E, Buchy P
    Vaccination against SARS-CoV-2 should be included in childhood vaccination programs.
    Int J Infect Dis. 2021 Apr 29. pii: S1201-9712(21)00394.
    >> Share

  547. CASTRO ABREU PINTO T, Silva Costa N, Andrade Oliveira LM
    The World Meningitis Day and the WHO roadmap to defeat bacterial meningitis in the COVID-19 pandemic era.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00382.
    >> Share

  548. GERHARDS C, Thiaucourt M, Kittel M, Becker C, et al
    Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescent from COVID-19 infection.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00392.
    >> Share

  549. LUO C, Liu M, Li Q, Zheng X, et al
    Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: multiple factors-based analysis.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00389.
    >> Share

  550. SONG Y, Chen C, Wang Y, Zhang J, et al
    Early and consecutive RT-PCR tests with both oropharyngeal swabs and sputum could improve testing yield for patients with COVID-19: An Observation Cohort Study in China.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00388.
    >> Share

  551. SORIANO V, de Mendoza C, Gomez-Gallego F, Corral O, et al
    Third wave of COVID-19 in Madrid, Spain.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00386.
    >> Share

  552. AZNAR ML, Espinosa-Pereiro J, Saborit N, Jove N, et al
    Impact of the COVID-19 pandemic on tuberculosis management in Spain.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00387.
    >> Share

  553. SEVILLANO G, Ortega-Paredes D, Loaiza K, Zurita-Salinas C, et al
    Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00385.
    >> Share

  554. AL-MAANI A, Al Wahaibi A, Al-Sooti J, Al Abri B, et al
    The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: a multicenter seroprevalence study.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00383.
    >> Share

  555. BRUZZONE B, De Pace V, Caligiuri P, Ricucci V, et al
    Comparative diagnostic performance of different rapid antigen detection tests for COVID-19 in the real-world hospital setting.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00384.
    >> Share

  556. LAGI F, Trevisan S, Piccica M, Graziani L, et al
    Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00377.
    >> Share

  557. LACAP EM JR, Varghese A, Khamis F, Bahrani MA, et al
    Development and Validation of CoV19-OM Intensive Care Unit Score: An Early ICU Identification for Laboratory-Confirmed SARS-CoV-2 Patients from a Retrospective Cohort Study in Oman.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00381.
    >> Share

  558. D'ABRAMO A, Vita S, Maffongelli G, Mariano A, et al
    Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: a tailored approach.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00380.
    >> Share

  559. RADULESCU A, Istrate A, Flonta M, Lupse M, et al
    Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted in a Romanian University Hospital of Infectious Diseases.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00379.
    >> Share

  560. CRUZ C, White NJ
    COVID-19 chemoprevention.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00356.
    >> Share

  561. LEBOURGEOIS S, Storto A, Gout B, Le Hingrat Q, et al
    Performance Evaluation of the QIAstat-Dx(R) Respiratory SARS-CoV-2 Panel.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00378.
    >> Share

  562. LEDNICKY JA, Lauzardo M, Alam MM, Elbadry MA, et al
    Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00375.
    >> Share

  563. NEKLUDOVA GV, Avdeev SN, Tsareva NA, Trushenko NV, et al
    Using TAPSE as a predictor of poor prognosis of COVID-19: is it enough?
    Int J Infect Dis. 2021 Apr 22. pii: S1201-9712(21)00368.
    >> Share

  564. AL-SAKKAF E, Ghaleb Y, Al-Dabis E, Qairan M, et al
    First COVID-19 Cases with High Secondary Infection among Health Workers, Sana'a Capital, April 2020: Lessons Learned and Future Opportunities.
    Int J Infect Dis. 2021 Apr 22. pii: S1201-9712(21)00333.
    >> Share

  565. ARNAUD DE, Apoline SK, Risgou OA, Lucien DD, et al
    Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): findings from hospital based cross-sectional study.
    Int J Infect Dis. 2021 Apr 21. pii: S1201-9712(21)00318.
    >> Share

  566. OSMAN W, Al Fahdi F, Khamis F, Salmi IA, et al
    Serum Calcium and Vitamin D levels correlation with severity of COVID-19 in hospitalized patients in Royal Hospital, Oman.
    Int J Infect Dis. 2021 Apr 20. pii: S1201-9712(21)00361.
    >> Share

  567. SUGHAYER MA, Mansour A, Al Nuirat A, Souan L, et al
    Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic.
    Int J Infect Dis. 2021 Apr 20. pii: S1201-9712(21)00371.
    >> Share

  568. BIRLUTIU V, Feiereisz AI, Oprinca G, Dobritoiu S, et al
    Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - a possible pattern? Observational study and review of the literature.
    Int J Infect Dis. 2021 Apr 19. pii: S1201-9712(21)00370.
    >> Share

  569. SIAMI Z, Aghajanian S, Mansouri S, Mokhames Z, et al
    Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: a randomized clinical trial.
    Int J Infect Dis. 2021 Apr 17. pii: S1201-9712(21)00354.
    >> Share

  570. CAPUTO V, Bax C, Colantoni L, Peconi C, et al
    Comparative analysis of antigen and molecular tests for the detection of Sars-CoV-2 and related variants: a study on 4266 samples.
    Int J Infect Dis. 2021 Apr 17. pii: S1201-9712(21)00359.
    >> Share

  571. HANSEN T, Titze U, Kulamadayil-Heidenreich NSA, Glombitza S, et al
    First case of postmortem study in a patient vaccinated against SARS CoV2.
    Int J Infect Dis. 2021 Apr 16. pii: S1201-9712(21)00364.
    >> Share

  572. KADALI RAK, Janagama R, Peruru S, Malayala SV, et al
    Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers.
    Int J Infect Dis. 2021 Apr 15. pii: S1201-9712(21)00358.
    >> Share

  573. AIELLO A, Fard SN, Petruccioli E, Petrone L, et al
    Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00344.
    >> Share

  574. SEET RCS, Quek AML, Ooi DSQ, Sengupta S, et al
    Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: an open-label randomized trial.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00345.
    >> Share

  575. MEHLER K, Jung N, Oberthuer A
    Is it all MIS-C? - Unusual findings in a series of nine German patients with multi-system inflammatory syndrome in children (MIS-C) after SARS-CoV2 infection.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00355.
    >> Share

  576. ROEST S, Brugts JJ, van Kampen JJA, von der Thusen JH, et al
    COVID-19-related myocarditis post-heart transplantation.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00324.
    >> Share

  577. GHAFARI M, Kadivar A, Katzourakis A
    Excess deaths associated with the Iranian COVID-19 epidemic: A province-level analysis.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00326.
    >> Share

  578. INABA M, Higashimoto Y, Toyama Y, Horiguchi T, et al
    Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00329.
    >> Share

  579. HU B, Ning P, Qiu J, Tao V, et al
    Modeling the complete spatiotemporal spread of the COVID-19 epidemic in mainland China.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00332.
    >> Share

  580. METTLER SK, Park J, Ozbek O, Mettler LK, et al
    Diagnostic Serial Interval as an Indicator for Effectiveness of Contact Tracing in the COVID-19 Pandemic - A Simulation Study.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00340.
    >> Share

  581. OULHAJ A, Alsuwaidi AR, Suliman A, Gasmelseed H, et al
    Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Associate with Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00337.
    >> Share

  582. MAKHOUL K, Shukha Y, Abu Hanna L, Nitecki S, et al
    A Case of Rapidly Progressive Upper Limb Ischemic Necrosis in a Patient with COVID-19.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00334.
    >> Share

  583. MORRIS CR, Iyer S
    Reply to Letter to the Editor regarding hospital-based triage travel screens during the COVID-19 pandemic.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00327.
    >> Share

  584. DEWI R, Kaswandani N, Karyanti MR, Setyant DB, et al
    Mortality in children with COVID-19: Lessons learned from a tertiary referral hospital in Indonesia.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00330.
    >> Share

  585. SCHADE W, Reimer V, Seipenbusch M, Willer U, et al
    Viral aerosol transmission of COVID-19 from simulated human emission in a concert hall.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00339.
    >> Share

  586. WU Q, Hou X, Li H, Guo J, et al
    A Follow-Up Study of Respiratory and Physical Functions After Discharge in re-detectable positive SARS-CoV-2 nucleic acid results in Recovered COVID-19 Patients.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00331.
    >> Share

  587. JAWADE K, Sinha AY, Bhagat S, Bhowmick S, et al
    A novel ORF-1a based SARS-CoV-2 RT-PCR assay to resolve inconclusive samples.
    Int J Infect Dis. 2021 Apr 11. pii: S1201-9712(21)00317.
    >> Share

  588. GABOR JJ, Kreidenweiss A, Weber S, Salama M, et al
    A call to caution when hydroxychloroquine is given to elderly COVID-19 patients.
    Int J Infect Dis. 2021 Apr 10. pii: S1201-9712(21)00320.
    >> Share

  589. SUEN YT, Chan RCH, Wong EMY
    An Exploratory Study of Factors Associated with Difficulties in Accessing HIV Services During COVID-19 among Chinese Gay and Bisexual Men in Hong Kong.
    Int J Infect Dis. 2021 Apr 9. pii: S1201-9712(21)00316.
    >> Share

  590. GOUVEA-REIS FA, Borja LS, Dias PO, Silva DCS, et al
    SARS-CoV-2 among inmates over 60 years of age during a COVID-19 outbreak in a penitentiary complex in Brazil: positive health outcomes despite high prevalence.
    Int J Infect Dis. 2021 Apr 9. pii: S1201-9712(21)00298.
    >> Share

  591. OLLIARO P, Torreele E
    Managing the risks of making the wrong diagnosis: First, do no harm.
    Int J Infect Dis. 2021 Apr 9. pii: S1201-9712(21)00315.
    >> Share

  592. XUE L, Jing S, Sun W, Liu M, et al
    Evaluating the impact of the travel ban within mainland China on the epidemic of the COVID-19.
    Int J Infect Dis. 2021 Apr 7. pii: S1201-9712(21)00306.
    >> Share

  593. FENG YF, Wang KP, Mo JG, Xu YH, et al
    The spatiotemporal trend of renal involvement in COVID-19: a pooled analysis of 17,134 patients.
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00300.
    >> Share

  594. JI Y, Shao J, Tao B, Song H, et al
    Are we ready to deal with a global COVID-19 pandemic? Rethinking countries' capacity based on the Global Health Security Index.
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00307.
    >> Share

  595. LAGIER JC, Amrane S, Mailhe M, Gainnier M, et al
    High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: a preliminary report.
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00305.
    >> Share

  596. GREENKY D, Linam M, Yaffee A, Costello B, et al
    Response to "Prevalence of SARS-CoV-2 Antibodies in Pediatric Healthcare Workers (pHCWs)".
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00310.
    >> Share

  597. TRACHOOTHAM D, Thongyen S, Lam-Ubol A, Chotechuang N, et al
    Simultaneously Complete but Not Partial Taste and Smell Losses were Associated with SAR-CoV-2 Infection.
    Int J Infect Dis. 2021 Apr 2. pii: S1201-9712(21)00301.
    >> Share

  598. BAUER G
    Comment to the manuscript by William P. Hausdorff and Jorge Flores: Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19, IJID 103 (2021) 37-41.
    Int J Infect Dis. 2021 Apr 2. pii: S1201-9712(21)00302.
    >> Share

  599. MICHOTTE N, Allard S, Payen MC, Dauby N, et al
    Aortic thrombosis in a patient with COVID-19-associated hyperinflammatory syndrome.
    Int J Infect Dis. 2021 Apr 1. pii: S1201-9712(21)00299.
    >> Share

  600. UDWADIA ZF, Barkate H, Patil S, Rangwala S, et al
    Response to the comments received on article "Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial" by Udwadia et a
    Int J Infect Dis. 2021;105:686-687.
    >> Share

  601. AL MOHAJER M, Panthagani KM, Lasco T, Lembcke B, et al
    Association between universal face shield in a quaternary care center and reduction of SARS-COV2 infections among healthcare personnel and hospitalized patients.
    Int J Infect Dis. 2021;105:252-255.
    >> Share

  602. PUECHMAILLE SJ, Ar Gouilh M, Dechmann D, Fenton B, et al
    Misconceptions and misinformation about bats and viruses.
    Int J Infect Dis. 2021;105:606-607.
    >> Share

  603. ZHOU F, Zhou XH
    Confusion about the definition of imported cases in the early stage of the epidemic.
    Int J Infect Dis. 2021;105:413.
    >> Share

    March 2021
  604. WANG Z, Wang Y, Yang Z, Wu H, et al
    The use of non-invasive ventilation in COVID-19: a systematic review.
    Int J Infect Dis. 2021 Mar 30. pii: S1201-9712(21)00296.
    >> Share

  605. NAGANO H, Takada D, Shin JH, Morishita T, et al
    Hospitalization of mild cases of community-acquired pneumonia decreased more than severe ones during the COVID-19 epidemic.
    Int J Infect Dis. 2021 Mar 29. pii: S1201-9712(21)00292.
    >> Share

  606. NACHEGA JB, Maeurer M, Sam-Agudu NA, Chakaya J, et al
    Bacille Calmette-Guerin (BCG) Vaccine and Potential Cross-Protection against SARS-CoV-2 Infection - Assumptions, Knowns, Unknowns and Need for Developing an Accurate Scientific Evidence Base.
    Int J Infect Dis. 2021 Mar 29. pii: S1201-9712(21)00279.
    >> Share

  607. FOURNIER PE, Colson P, Levasseur A, Devaux CA, et al
    Emergence and outcome of the SARS-CoV-2 "Marseille-4" variant.
    Int J Infect Dis. 2021 Mar 27. pii: S1201-9712(21)00286.
    >> Share

  608. DENNISON D, Khabori MA, Mamari SA, Aurelio A, et al
    Circulating activated neutrophils in COVID-19: an independent predictor for mechanical ventilation and death.
    Int J Infect Dis. 2021 Mar 26. pii: S1201-9712(21)00284.
    >> Share

  609. VELAVAN TP, Meyer CG, Esen M, Kremsner PG, et al
    COVID-19 and Syndemic challenges in 'Battling the Big Three': HIV, TB and malaria.
    Int J Infect Dis. 2021 Mar 26. pii: S1201-9712(21)00289.
    >> Share

  610. CHEW NWS, Cheong C, Kong G, Phua K, et al
    An Asia-Pacific study on healthcare worker's perception and willingness to receive COVID-19 vaccination.
    Int J Infect Dis. 2021 Mar 26. pii: S1201-9712(21)00287.
    >> Share

  611. KNIPPER M, Sedas AC, Keshavjee S, Abbara A, et al
    The need for protecting and enhancing TB health policies and services for forcibly displaced and migrant populations during the ongoing COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 25. pii: S1201-9712(21)00265.
    >> Share

  612. NYASULU JCY, Munthali RJ, Nyondo-Mipando AL, Pandya H, et al
    COVID-19 pandemic in Malawi: Did public social-political events gatherings contribute to its first wave local transmission?
    Int J Infect Dis. 2021 Mar 23. pii: S1201-9712(21)00273.
    >> Share

  613. BARRY M, Althabit N, Akkielah L, AlMohaya A, et al
    Clinical Characteristics and Outcomes of Hospitalized COVID-19 Patients in a MERS-CoV Referral Hospital during the Peak of the Pandemic.
    Int J Infect Dis. 2021 Mar 23. pii: S1201-9712(21)00276.
    >> Share

  614. MACINTYRE CR, Nguyen PY, Chughtai AA, Trent M, et al
    Mask use, risk mitigation behaviours and pandemic fatigue during the COVID-19 pandemic in five cities in Australia, the UK and USA: a cross-sectional survey.
    Int J Infect Dis. 2021 Mar 23. pii: S1201-9712(21)00274.
    >> Share

  615. NACHEGA JB, Kapata N, Sam-Agudu NA, Decloedt EH, et al
    Minimizing the Impact of the Triple Burden of COVID-19, Tuberculosis and HIV on Health Services in sub-Saharan Africa.
    Int J Infect Dis. 2021 Mar 20. pii: S1201-9712(21)00256.
    >> Share

  616. LISEWSKI AM
    Interim estimates in null models of COVID-19 vaccine effectiveness.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00268.
    >> Share

  617. ZUMLA A, Chakaya J, Khan M, Fatima R, et al
    World Tuberculosis Day 2021 Theme - 'THE CLOCK IS TICKING' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00264.
    >> Share

  618. MBOUMBA BOUASSA RS, Veyer D, Pere H, Belec L, et al
    Analytical performances of the point-of-care SIENNA COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00269.
    >> Share

  619. MURAI Y, Kawasuji H, Takegoshi Y, Kaneda M, et al
    A case of COVID-19 diagnosed with favipiravir induced drug fever based on positive drug-induced lymphocyte stimulation test.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00266.
    >> Share

  620. GABBRIELLI M, Gandolfo C, Anichini G, Candelori T, et al
    How long can SARS-CoV-2 persist in human corpses?
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00270.
    >> Share

  621. EL-SAED A, Alshamrani MM
    RE: COVID-19 and healthcare workers: A systematic review and meta-analysis.
    Int J Infect Dis. 2021 Mar 17. pii: S1201-9712(21)00247.
    >> Share

  622. ECOCHARD R, Wimba P, Bengehya J, Bianga PK, et al
    The COVID-19 pandemic is deepening the health crisis in South Kivu.
    Int J Infect Dis. 2021 Mar 17. pii: S1201-9712(21)00261.
    >> Share

  623. FATIMA R, Akhtar N, Yaqoob A, D Harries A, et al
    Building better tuberculosis control systems in a post-COVID world: learning from Pakistan during the COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 17. pii: S1201-9712(21)00244.
    >> Share

  624. ABRAHA HE, Gessesse Z, Gebrecherkos T, Kebede Y, et al
    Clinical Features and Risk Factors Associated with Morbidity and Mortality Among COVID-19 Patients in Northern Ethiopia.
    Int J Infect Dis. 2021 Mar 16. pii: S1201-9712(21)00255.
    >> Share

  625. ALKINDI S, Elsadek RA, Al-Madhani A, Al-Musalhi M, et al
    Impact of the coronavirus 2019 (COVID-19) on vasooclusive crisis in patients with sickle cell anaemia.
    Int J Infect Dis. 2021 Mar 16. pii: S1201-9712(21)00262.
    >> Share

  626. GHOLAMI M, Khamis AH, Ho SB
    Response to "RE: COVID-19 and healthcare workers: A systematic review and meta-analysis."
    Int J Infect Dis. 2021 Mar 16. pii: S1201-9712(21)00252.
    >> Share

  627. NISAR MI, Ansari N, Khalid F, Amin M, et al
    Serial population-based sero-surveys for COVID-19 in two neighborhoods of Karachi, Pakistan.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00258.
    >> Share

  628. NOUSHAD M, Al-Saqqaf ISA
    COVID-19: Is herd immunity, the only option for fragile Yemen?
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00248.
    >> Share

  629. ZINELLU A, Paliogiannis P, Carru C, Mangoni AA, et al
    Serum amyloid A concentrations, COVID-19 severity and mortality: an updated systematic review and meta-analysis.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00243.
    >> Share

  630. NTOUMI F, Mapanguy CCM, Tomazatos A, Pallerla SR, et al
    Genomic surveillance of SARS-CoV-2 in the Republic of Congo.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00254.
    >> Share

  631. BASARAN S, Simsek-Yavuz S, Mese S, Cagatay A, et al
    The effect of tocilizumab, anakinra, and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00249.
    >> Share

  632. TANG M, Zhang H, Cai J
    Coronavirus disease 2019 in pregnancy - letter to the editor.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00245.
    >> Share

  633. MORRIS CR, Sullivan P, Mantus G, Sanchez T, et al
    Prevalence of SARS-CoV-2 Antibodies in Pediatric Healthcare Workers.
    Int J Infect Dis. 2021 Mar 12. pii: S1201-9712(21)00234.
    >> Share

  634. BAVARO DF, Diella L, Fabrizio C, Sulpasso R, et al
    Peculiar clinical presentation of COVID- 19 and predictors of mortality in the elderly: a Multicentre Retrospective Cohort Study.
    Int J Infect Dis. 2021 Mar 12. pii: S1201-9712(21)00239.
    >> Share

  635. SAHU S, Ditiu L, Singh Sachdeva K, Zumla A, et al
    Recovering from the Impact of the Covid-19 Pandemic and Accelerating to Achieving the United Nations General Assembly Tuberculosis Targets.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00164.
    >> Share

  636. CHAKAYA J, Khan M, Ntoumi F, Aklillu E, et al
    Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00193.
    >> Share

  637. MATHEVET I, Ost K, Traverson L, Zinszer K, et al
    Accounting for health inequities in the design of contact tracing interventions: a rapid review.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00227.
    >> Share

  638. KIZNY GORDON A, Marais B, Walker TM, Sintchenko V, et al
    Clinical and public health utility of Mycobacterium tuberculosis whole genome sequencing.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00200.
    >> Share

  639. BAUER G
    The potential significance of high avidity IgG for protective immunity towards SARS-CoV-2.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00072.
    >> Share

  640. PANDIT A, Bhalani N, Bhushan BLS, Koradia P, et al
    Efficacy and Safety of Pegylated Interferon alfa-2b in Moderate COVID-19: A phase II, randomized, controlled, open-label study.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00232.
    >> Share

  641. PETRONE L, Petruccioli E, Vanini V, Cuzzi G, et al
    Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00176.
    >> Share

  642. TIBERI S, Vjecha MJ, Zumla A, Galvin J, et al
    Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00153.
    >> Share

  643. TEN-CATEN F, Gonzalez-Dias P, Castro I, Ogava RLT, et al
    In-depth Analysis of Laboratory Parameters Reveals the Interplay Between Sex, Age and Systemic Inflammation in Individuals with COVID-19.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00233.
    >> Share

  644. KOCK R, Michel AL, Yeboah-Manu D, Azhar EI, et al
    Zoonotic tuberculosis - The changing landscape.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00177.
    >> Share

  645. NETO FL, Salzstein GA, Cortez AL, Bastos TL, et al
    Comparative Assessment of Mortality Risk Factors Between Admission and Follow-up Models Among Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00230.
    >> Share

  646. ALISHAQ M, Jeremijenko A, Nafady-Hego H, Al Ajmi JA, et al
    SARS-CoV-2 Infection in Mortuary and Cemetery Workers.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00229.
    >> Share

  647. WANG Q, Dong W, Yang K, Ren Z, et al
    Temporal and spatial analysis of COVID-19 transmission in China and its influencing factors.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00231.
    >> Share

  648. KAYA H, Kaji M, Usuda D
    Soluble interleukin-2 receptor levels on admission associated with mortality in coronavirus disease 2019.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00228.
    >> Share

  649. WUNGU CDK, Khaerunnisa S, Putri EAC, Hidayati HB, et al
    Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00225.
    >> Share

  650. SORIANO V, Ganado-Pinilla P, Sanchez-Santos M, Gomez-Gallego F, et al
    Main Differences Between the First and Second Waves of COVID-19 in Madrid, Spain.
    Int J Infect Dis. 2021 Mar 5. pii: S1201-9712(21)00201.
    >> Share

  651. CALISTRI P, Amato L, Puglia I, Cito F, et al
    Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs.
    Int J Infect Dis. 2021 Mar 5. pii: S1201-9712(21)00210.
    >> Share

  652. CHAN AX, Ritter M, Bakhoum MF
    Bilateral cotton wool spots after ambulatory COVID-19.
    Int J Infect Dis. 2021 Mar 5. pii: S1201-9712(21)00205.
    >> Share

  653. MONDI A, Lorenzini P, Castilletti C, Gagliardini R, et al
    Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted in an Italian Reference Hospital.
    Int J Infect Dis. 2021 Mar 3. pii: S1201-9712(21)00203.
    >> Share

  654. BERNAS SN, Baldauf H, Wendler S, Heidenreich F, et al
    CCR5Delta32 mutations do not determine COVID-19 disease course.
    Int J Infect Dis. 2021 Mar 2. pii: S1201-9712(21)00195.
    >> Share

  655. WIBOWO A, Pranata R, Akbar MR, Purnomowati A, et al
    The Prognostic Performance of Troponin in COVID-19: A Diagnostic Meta-analysis and Meta-regression.
    Int J Infect Dis. 2021 Mar 2. pii: S1201-9712(21)00199.
    >> Share

  656. LINTON NM, Akhmetzhanov AR, Nishiura H
    Localized end-of-outbreak determination for coronavirus disease 2019 (COVID-19): examples from clusters in Japan.
    Int J Infect Dis. 2021 Mar 1. pii: S1201-9712(21)00192.
    >> Share

    February 2021
  657. BOUDJELAL M, Almajed F, Salman AM, Alharbi NK, et al
    COVID-19 Vaccines: Global Challenges and Prospects Forum Recommendations.
    Int J Infect Dis. 2021 Feb 27. pii: S1201-9712(21)00179.
    >> Share

  658. MEHTA RM, Bansal S, Bysani S, Kalpakam H, et al
    A shorter symptom-onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: a real-world analysis.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00178.
    >> Share

  659. ALMADHI MA, Abdulrahman A, Sharaf SA, AlSaad D, et al
    The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00186.
    >> Share

  660. LOPEZ-MEDRANO F, Perez-Jacoiste Asin MA, Fernandez-Ruiz M, Carretero O, et al
    Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: a single-center retrospective study.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00185.
    >> Share

  661. BYEON KH, Kim DW, Kim J, Choi BY, et al
    Factors Affecting the Survival of Early COVID-19 Patients in South Korea: An Observational Study based on the Korean National Health Insurance Big Data.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00187.
    >> Share

  662. GILI A, Paggi R, Russo C, Cenci E, et al
    Evaluation of automated test Lumipulse(R) G SARS-CoV-2 antigen assay for detection of SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00184.
    >> Share

  663. LU G, Muller O, Li Y
    Imported covid-19 cases: a hot topic with a lack of a clear definition.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00167.
    >> Share

  664. BENNASRALLAH C, Zemni I, Dhouib W, Sriha H, et al
    Factors Associated with a prolonged negative conversion of viral RNA in patients with Coronavirus Disease 2019 (COVID-19).
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00175.
    >> Share

  665. RODRIGUEZ A, Arrizabalaga M, Fernandez-Baca V, Lainez MP, et al
    Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of COVID-19 pandemic.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00190.
    >> Share

  666. SINGH V, Upadhyay P, Reddy J, Granger J, et al
    SARS-CoV-2 Respiratory Co-Infections: Incidence of Viral and Bacterial Co-Pathogens.
    Int J Infect Dis. 2021 Feb 25. pii: S1201-9712(21)00173.
    >> Share

  667. FRANCO-PAREDES C, Suarez JA, Henao-Martinez AF
    Correspondence Global COVID-19 Vaccine Equity Should Precede Requiring Travelers Proof of Vaccination.
    Int J Infect Dis. 2021 Feb 25. pii: S1201-9712(21)00147.
    >> Share

  668. PETERSEN E, Lucey D, Blumberg L, Kramer LD, et al
    Answer to Paredes et al. commenting on "COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis".
    Int J Infect Dis. 2021 Feb 24. pii: S1201-9712(21)00162.
    >> Share

  669. HOANG VT
    Comment to Sands et al: No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
    Int J Infect Dis. 2021 Feb 24. pii: S1201-9712(21)00165.
    >> Share

  670. DUGAS M, Grote-Westrick T, Vollenberg R, Lorentzen E, et al
    Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1).
    Int J Infect Dis. 2021 Feb 23. pii: S1201-9712(21)00171.
    >> Share

  671. VETTER M, Kaufmann MD, Neurath MF, Kremer AE, et al
    Purple Urine in a Patient after Recovery from a SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 Feb 23. pii: S1201-9712(21)00169.
    >> Share

  672. MUNOZ M, Patino LH, Ballesteros N, Paniz-Mondolfi A, et al
    Characterizing SARS-CoV-2 genome diversity circulating in South American countries: signatures of potentially emergent lineages?
    Int J Infect Dis. 2021 Feb 19. pii: S1201-9712(21)00159.
    >> Share

  673. NAKAJO K, Nishiura H
    Transmissibility of asymptomatic COVID-19: Data from Japanese clusters.
    Int J Infect Dis. 2021 Feb 19. pii: S1201-9712(21)00151.
    >> Share

  674. NG JKC, Ngai JCL, Ng SSS, Hui DSC, et al
    Collection of Lower Respiratory Specimen by Bronchoscopy for Diagnosis of COVID-19.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00152.
    >> Share

  675. CYPRIAN F, Sohail MU, Abdelhafez I, Salman S, et al
    SARS-CoV-2-Immune-Microbiome Interaction: Lessons from Respiratory Viral Infections.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00156.
    >> Share

  676. SHANKAR H, Champati Ray PK
    GIS-Based Analysis of COVID-19 Cases in India during Pre-lockdown, Lockdown and Unlock Phases.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00157.
    >> Share

  677. BUTTERFIELD TR, Bruce-Mowatt A, Phillips YZR, Brown N, et al
    Assessment of Commercial SARS-CoV-2 Antibody Assays, Jamaica.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00145.
    >> Share

  678. THOMMES L, Burkert FR, Ottl KW, Goldin D, et al
    Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients.
    Int J Infect Dis. 2021 Feb 17. pii: S1201-9712(21)00138.
    >> Share

  679. HUANG E, Isonaka S, Yang H, Salce E, et al
    Tocilizumab Treatment in Critically Ill Patients with COVID-19: A Retrospective Observational Study.
    Int J Infect Dis. 2021 Feb 17. pii: S1201-9712(21)00143.
    >> Share

  680. CHOI YJ, Park MJ, Park SJ, Hong D, et al
    Types of COVID-19 clusters and their relationship with social distancing in Seoul Metropolitan area in South Korea.
    Int J Infect Dis. 2021 Feb 17. pii: S1201-9712(21)00144.
    >> Share

  681. TWOREK A, Jaron K, Uszynska-Kaluza B, Rydzewski A, et al
    Convalescent plasma treatment is associated with lower mortality and better outcomes in high risk COVID-19 patients - propensity score matched case-control study.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00140.
    >> Share

  682. MAYNARD S, Ros-Soto J, Chaidos A, Innes A, et al
    The role of ibrutinib in COVID-19 hyperinflammation: a case report.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00142.
    >> Share

  683. MUMOLI N, Florian C, Cei M, Evangelista I, et al
    Palliative care in a COVID-19 Internal Medicine Ward: a preliminary report.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00139.
    >> Share

  684. DAVIDO B, Gautier S, Riom I, Landowski S, et al
    First wave of COVID-19 in hospital staff members of a tertiary care hospital in the greater Paris area: surveillance and risk factors study.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00141.
    >> Share

  685. MEDISETTY MK, Patel A, Pujari S
    Letter to the editor on "Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial" by Udwadia Z et al.
    Int J Infect Dis. 2021 Feb 15. pii: S1201-9712(21)00121.
    >> Share

  686. AL SULAIMAN KA, Al Juhani OA, Eljaaly K, Alharbi AA, et al
    Clinical Features and Outcomes of Critically Ill Patients with Coronavirus Disease 2019 (COVID-19): A Multicenter Cohort Study.
    Int J Infect Dis. 2021 Feb 15. pii: S1201-9712(21)00123.
    >> Share

  687. ORTIZ-PRADO E, Rivera-Olivero IA, Freire-Paspuel B, Lowe R, et al
    Testing for SARS-CoV-2 at the core of voluntary collective isolation: Lessons from the indigenous populations living in the Amazon region in Ecuador.
    Int J Infect Dis. 2021 Feb 13. pii: S1201-9712(21)00125.
    >> Share

  688. DE LA CALLE C, Lopez-Medrano F, Pablos JL, Lora-Tamayo J, et al
    Effectiveness of anakinra for tocilizumab-refractory severe COVID-19. A single centre retrospective comparative study.
    Int J Infect Dis. 2021 Feb 13. pii: S1201-9712(21)00127.
    >> Share

  689. STEUWER B, Jamrozik E, Eyal N
    Prioritizing between second-generation SARS-CoV-2 vaccines through low-dosage challenge studies.
    Int J Infect Dis. 2021 Feb 13. pii: S1201-9712(21)00124.
    >> Share

  690. YANG Q, Xiao X, Gu X, Liang D, et al
    Surveillance of common respiratory infections during COVID-19 pandemic demonstrates preventive effectiveness of non-pharmaceutical interventions.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00113.
    >> Share

  691. ONYEGHALA C, Alasia D, Eyaru O, Nsirim P, et al
    Multisystem Inflammatory Syndrome (MIS-C) in an Adolescent Nigerian Girl with COVID-19: A call for vigilance in Africa.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00103.
    >> Share

  692. MARTHA JW, Pranata R, Wibowo A, Lim MA, et al
    Tricuspid Annular Plane Systolic Excursion (TAPSE) Measured by Echocardiography and Mortality in COVID-19: A Systematic Review and Meta-analysis.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00115.
    >> Share

  693. ECHEVERRIA G, Guevara A, Coloma J, Ruiz AM, et al
    Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00120.
    >> Share

  694. MAIA CMF, Marques NP, de Lucena EHG, de Rezende LF, et al
    Increase in the number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00119.
    >> Share

  695. HERRERA LA, Hidalgo-Miranda A, Reynoso-Noveron N, Meneses-Garcia AA, et al
    Saliva is a reliable and accessible source for the detection of SARS-CoV-2.
    Int J Infect Dis. 2021 Feb 10. pii: S1201-9712(21)00095.
    >> Share

  696. YI B, Fen G, Cao D, Cai Y, et al
    Epidemiological and clinical characteristics of 214 families with COVID-19 in Wuhan, China.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00106.
    >> Share

  697. BORDONI V, Tartaglia E, Sacchi A, Fimia GM, et al
    The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00105.
    >> Share

  698. KITTEL M, Findeisen P, Muth MC, Thiaucourt M, et al
    Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys(R) Anti-SARS-CoV-2 immunoassay.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00110.
    >> Share

  699. ABDI A, Ahmed AY, Mohamed A, Karanja M, et al
    Preliminary findings of COVID-19 infection in health workers in Somalia: a reason for concern.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00078.
    >> Share

  700. LIMA-MORALES R, Mendez-Hernandez P, Flores YN, Osorno-Romero P, et al
    Effectiveness of a multidrug therapy consisting of ivermectin, azithromycin, montelukast and acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00100.
    >> Share

  701. LY TDA, Nguyen NN, Hoang VT, Goumballa N, et al
    Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March-April 2020.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00112.
    >> Share

  702. SAIDI O, Malouche D, Saksena P, Arfaoui L, et al
    Impact of contact tracing, respect of isolation and lockdown in reducing the number of cases infected with COVID-19: Case study: Tunisia's response from March 22 to 04 May 2020.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00096.
    >> Share

  703. DARBANDI A, Asadi A, Ghanavati R, Afifirad R, et al
    The Effect of Probiotics on Respiratory Tract Infection with Special Emphasis on COVID-19: A Periodic Review during 2010-2020.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00097.
    >> Share

  704. LIU J, Liu J, He Z, Yang Z, et al
    The duration of SARS-CoV-2 positive in the environments of quarantine rooms: a perspective analysis.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00111.
    >> Share

  705. HIROTSU Y, Maejima M, Shibusawa M, Amemiya K, et al
    Prospective Study of 1,308 Nasopharyngeal Swabs from 1,033 Patients using the LUMIPULSE SARS-CoV-2 Antigen Test: Comparison with RT-qPCR.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00090.
    >> Share

  706. PALKA-KOTLOWSKA M, Custodio-Cabello S, Oliveros-Acebes E, Khosravi-Shahi P, et al
    Review of risk of covid-19 in cancer patients and their cohabitants.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00085.
    >> Share

  707. SEONG H, Hyun HJ, Yun JG, Noh JY, et al
    Comparison of the second and third waves of the COVID-19 pandemic in South Korea: Importance of early public health intervention.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00089.
    >> Share

  708. BISWAS S, Sukla S, Roy S, Nath H, et al
    Response to: Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00074.
    >> Share

  709. ELIAS C, Sekri A, Leblanc P, Cucherat M, et al
    Incubation period of COVID-19: a meta-analysis.
    Int J Infect Dis. 2021 Feb 3. pii: S1201-9712(21)00081.
    >> Share

  710. LAU K, Dorigatti I, Miraldo M, Hauck K, et al
    SARIMA-modelled greater severity and mortality during the 2010/11 post-pandemic influenza season compared to the 2009 H1N1 pandemic in English hospitals.
    Int J Infect Dis. 2021 Feb 3. pii: S1201-9712(21)00082.
    >> Share

  711. SANGINETO M, Arena F, De Nittis R, Villani R, et al
    Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: analysis of 944 patients in Apulia, Italy.
    Int J Infect Dis. 2021 Feb 2. pii: S1201-9712(21)00080.
    >> Share

  712. CAZELLES B, Comiskey C, Nguyen Van Yen B, Champagne C, et al
    Identical trends of SARS-Cov-2 transmission and retail and transit mobility during non-lockdown periods.
    Int J Infect Dis. 2021 Feb 1. pii: S1201-9712(21)00079.
    >> Share

  713. ZHANG J, Xu J, Zhou S, Wang C, et al
    The characteristics of 527 discharged COVID-19 patients undergoing long-term follow-up in China.
    Int J Infect Dis. 2021 Feb 1. pii: S1201-9712(21)00075.
    >> Share

  714. LEE TC, McDonald EG, Butler-Laporte G, Harrison LB, et al
    Remdesivir and Systemic Corticosteroids for the Treatment of COVID-19: A Bayesian Reanalysis.
    Int J Infect Dis. 2021 Feb 1. pii: S1201-9712(21)00077.
    >> Share

    January 2021
  715. OGUZ F, Paseau T, Reper P
    A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer: if early cytokines scoring results available, to compare with existing severity scores and CT scan observations.
    Int J Infect Dis. 2021 Jan 30. pii: S1201-9712(21)00070.
    >> Share

  716. DIAZ H, Espana G, Castaneda N, Rodriguez L, et al
    Dynamical characteristics of Covid-19 epidemic: Estimation from Colombia's case.
    Int J Infect Dis. 2021 Jan 30. pii: S1201-9712(21)00064.
    >> Share

  717. GUPTA D
    Why are COVID-19 fatality rates among medical doctors higher than those among medical nurses?
    Int J Infect Dis. 2021 Jan 29. pii: S1201-9712(21)00061.
    >> Share

  718. PENARRUBIA L, Ruiz M, Porco R, Rao SN, et al
    In Response to: Multiple assays in a real-time RT-PCR Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.
    Int J Infect Dis. 2021 Jan 27. pii: S1201-9712(21)00060.
    >> Share

  719. LI H, Xiong N, Li C, Gong Y, et al
    Efficacy of ribavirin and interferon-alpha therapy for hospitalized patients with COVID-19: a multicenter, retrospective cohort study.
    Int J Infect Dis. 2021 Jan 27. pii: S1201-9712(21)00066.
    >> Share

  720. MORETTO F, Sixt T, Devilliers H, Abdallahoui M, et al
    Is there a need to widely prescribe antibiotics in patients hospitalized for COVID-19?
    Int J Infect Dis. 2021 Jan 25. pii: S1201-9712(21)00062.
    >> Share

  721. ORONSKY B, Gruber HE, Reiners W, Reid TR, et al
    A Short Discussion About The SARS-CoV-2 mRNA-1273 Vaccine.
    Int J Infect Dis. 2021 Jan 22. pii: S1201-9712(21)00059.
    >> Share

  722. JIAN SW, Kao CT, Chang YC, Chen PF, et al
    Risk Assessment for COVID-19 Pandemic in Taiwan.
    Int J Infect Dis. 2021 Jan 21. pii: S1201-9712(21)00054.
    >> Share

  723. SIDDIQUI SN, Jayasekhar R, Tshering S, Jugjali R, et al
    A Unique Tale of COVID-19 Induced Concomitant Overt DIC and Acute Bi-lateral Pulmonary Embolism.
    Int J Infect Dis. 2021 Jan 21. pii: S1201-9712(21)00051.
    >> Share

  724. LIAO M, Wu J, Dai M, Li H, et al
    Rapid detection of SARS-CoV-2 under replicating or non-replicating status in samples using RT-PCR.
    Int J Infect Dis. 2021 Jan 21. pii: S1201-9712(21)00053.
    >> Share

  725. MOSTAFA A, Kandil S, El-Sayed MH, Girgis S, et al
    SARS-CoV-2 seroconversion among 4040 Egyptian healthcare workers in 12 resource-limited healthcare facilities: A prospective cohort study.
    Int J Infect Dis. 2021 Jan 20. pii: S1201-9712(21)00048.
    >> Share

  726. SERRE-MIRANDA C, Nobrega C, Roque S, Canto-Gomes J, et al
    Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalized COVID-19 patients.
    Int J Infect Dis. 2021 Jan 20. pii: S1201-9712(21)00049.
    >> Share

  727. NG CFS, Seposo XT, Moi ML, Tajudin MABA, et al
    Erratum to "Characteristics of COVID-19 epidemic and control measures to curb transmission in Malaysia" [Int J Infect Dis 101 (December) (2020) 409-411].
    Int J Infect Dis. 2021 Jan 19. pii: S1201-9712(21)00034.
    >> Share

  728. PETERSEN E, Lucey D, Blumberg L, Kramer LD, et al
    COVID-19 vaccines under the International Health Regulations - we must use the WHO International Certificate of Vaccination or Prophylaxis.
    Int J Infect Dis. 2021 Jan 19. pii: S1201-9712(21)00050.
    >> Share

  729. HOONG CWS, Amin MNME, Tan TC, Lee JE, et al
    Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms.
    Int J Infect Dis. 2021 Jan 18. pii: S1201-9712(21)00043.
    >> Share

  730. SCARABEL L, Guardascione M, Dal Bo M, Toffoli G, et al
    Pharmacological strategies to prevent SARS-CoV-2 infection and to treat the early phases of COVID-19 disease.
    Int J Infect Dis. 2021 Jan 18. pii: S1201-9712(21)00046.
    >> Share

  731. AL YAZIDI LS, Al Hinai Z, Al Waili B, Al Hashami H, et al
    Epidemiology, characteristics, and outcomes of hospitalized children with COVID-19 in Oman: A multicenter cohort study.
    Int J Infect Dis. 2021 Jan 18. pii: S1201-9712(21)00047.
    >> Share

  732. BANJAR A, Al-Tawfiq JA, Alruwaily A, Alserehi H, et al
    Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early month of the pandemic in Saudi Arabia.
    Int J Infect Dis. 2021 Jan 16. pii: S1201-9712(21)00040.
    >> Share

  733. WILBURN J, Blakey E, Trindall A, Burr H, et al
    COVID-19 within a large prison with high number of vulnerable adults in the UK, March to June 2020: an outbreak investigation and screening event.
    Int J Infect Dis. 2021 Jan 16. pii: S1201-9712(21)00038.
    >> Share

  734. ELEC AD, Oltean M, Goldis P, Cismaru C, et al
    COVID-19 after kidney transplantation: Early outcome and renal function following antiviral treatment.
    Int J Infect Dis. 2021 Jan 13. pii: S1201-9712(21)00033.
    >> Share

  735. DASH P, Turuk J, Behera SK, Palo SK, et al
    Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutated receptor binding domain with ACE2 receptor.
    Int J Infect Dis. 2021 Jan 12. pii: S1201-9712(21)00029.
    >> Share

  736. CHEN M, Qin R, Mei J, Yang Z, et al
    Clinical applications of detecting IgG, IgM, or IgA antibody for the diagnosis of COVID-19: A meta-analysis and systematic review.
    Int J Infect Dis. 2021 Jan 12. pii: S1201-9712(21)00026.
    >> Share

  737. CHEN C, Zhu C, Yan D, Liu H, et al
    The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): A systematic review and meta-analysis.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00027.
    >> Share

  738. GHOLAMI M, Fawad I, Shadan S, Rowaiee R, et al
    COVID-19 and Healthcare Workers: A Systematic Review and Metaanalysis.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00023.
    >> Share

  739. MARCOLINO MS, Ziegelmann PK, Souza-Silva MVR, do Nascimento IJB, et al
    Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: results from the Brazilian COVID-19 Registry.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00030.
    >> Share

  740. SHAYAK B, Sharma MM, Gaur M, Mishra AK, et al
    Impact of reproduction number on multiwave spreading dynamics of COVID-19 with temporary immunity: a mathematical model.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00028.
    >> Share

  741. HUANG C, Fei L, Li W, Xu W, et al
    Efficacy Evaluation of Intravenous Immunoglobulin in Non-severe Patients with COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00015.
    >> Share

  742. MELIS M, Littera R
    Undetected infectives in the Covid-19 pandemic.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00018.
    >> Share

  743. FREIRE-PASPUEL B, Garcia-Bereguiain MA
    Low Clinical Performance of "Isopollo COVID19 detection kit" (Monitor, South Korea) for RT-LAMP SARS-CoV-2 diagnosis: a call for action against low quality products for developing countries.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00017.
    >> Share

  744. FERNANDEZ-ROJAS MA, Esparza MAL, Romero AC, Calva-Espinosa DY, et al
    Epidemiology of COVID-19 in Mexico, symptomatic profiles and presymptomatic people.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00012.
    >> Share

  745. LUCIEN MAB, Canarie MF, Kilgore PE, Jean-Denis G, et al
    Antibiotics and Antimicrobial Resistance in the COVID-19 Era.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00016.
    >> Share

  746. SOKHNA C, Goumballa N, Hoang VT, Bassene H, et al
    The Grand Magal of Touba was spared by the COVID-19 pandemic.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00011.
    >> Share

  747. DA SILVA QUEIROZ JA, de Cassia Pontello Rampazzo R, da Silva Filho EB, Oliveira GS, et al
    Development of a quantitative one-step multiplex RT-qPCR assay for the detection of SARS-CoV-2 in a biological matrix.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00002.
    >> Share

  748. TANDON M, Kataria S, Patel J, Mehta TR, et al
    A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00003.
    >> Share

  749. MARZIALI ME, Hogg RS, Oduwole OA, Card KG, et al
    Predictors of COVID-19 testing rates: A cross-country comparison.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00005.
    >> Share

  750. LUBNOW M, Schmidt B, Fleck M, Salzberger B, et al
    Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: balancing immunosuppression.
    Int J Infect Dis. 2021 Jan 4. pii: S1201-9712(20)32571.
    >> Share

  751. YAMAMOTO K, Suzuki M, Yamada G, Sudo T, et al
    Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32603.
    >> Share

  752. IHLOW J, Michaelis E, Greuel S, Heynol V, et al
    B Cell Depletion and Signs of Sepsis Acquired Immunodeficiency in Bone Marrow and Spleen of COVID-19 Deceased.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32602.
    >> Share

  753. KU CW, Durai S, Kwan JQT, Loy SL, et al
    Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32604.
    >> Share

  754. LIU N, Sun J, Wang X, Zhang T, et al
    Low vitamin D status is associated with coronavirus disease 2019 outcomes: A systematic review and meta-analysis.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32600.
    >> Share

  755. KOZLOVSKAYA L, Piniaeva A, Ignatyev G, Selivanov A, et al
    Corrigendum to isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak [Int. J. Infect. Dis. 99 (2020) 40-46].
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32543.
    >> Share

    December 2020
  756. FOY BH, Wahl B, Mehta K, Shet A, et al
    Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study.
    Int J Infect Dis. 2020;103:431-438.
    >> Share

  757. GENERALI D, Bosio G, Malberti F, Cuzzoli A, et al
    Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study.
    Int J Infect Dis. 2020 Dec 29. pii: S1201-9712(20)32597.
    >> Share

  758. LATIANO A, Tavano F, Panza A, Palmieri O, et al
    False Positive Results Of IgM/IgG antibodies against antigen of the SARS-CoV-2 in sera stored before the 2020 Endemia in Italy.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32591.
    >> Share

  759. ROHIT A, Rajasekaran S, Shenoy S, Rai S, et al
    Reprocessing of N95 masks: our experience from a resource limited setting in India.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32594.
    >> Share

  760. LO SH, Lin CY, Hung CT, He JJ, et al
    The impact of universal face masking and enhanced hand hygiene for COVID-19 disease prevention on the incidence of hospital acquired infections in a Taiwanese hospital.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32596.
    >> Share

  761. IENI A, Tuccari G
    The COVID-19 pandemic: pathologist's support to clinical infectious team.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32593.
    >> Share

  762. BABU GR, Khetrapal S, John DA, Deepa R, et al
    Pandemic Preparedness and Response to COVID-19 in South Asian Countries.
    Int J Infect Dis. 2020 Dec 25. pii: S1201-9712(20)32572.
    >> Share

  763. BATCHI-BOUYOU AL, Lobaloba L, Ndounga M, Vouvoungui JC, et al
    High SARS-COV2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.
    Int J Infect Dis. 2020 Dec 25. pii: S1201-9712(20)32589.
    >> Share

  764. CORTES MF, Espinoza EPS, Noguera SLV, Silva AA, et al
    Decontamination and reuse of surgical masks and respirators during COVID-19 pandemic.
    Int J Infect Dis. 2020 Dec 23. pii: S1201-9712(20)32580.
    >> Share

  765. SANDS K, Wenzel R, McLean L, Korwek K, et al
    No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
    Int J Infect Dis. 2020 Dec 23. pii: S1201-9712(20)32583.
    >> Share

  766. WAHAIBI AA, Al-Maani A, Alyaquobi F, Harthy KA, et al
    Effects of COVID-19 on mortality: a 5-year population-based study in Oman.
    Int J Infect Dis. 2020 Dec 22. pii: S1201-9712(20)32578.
    >> Share

  767. LIU Y, Tang JW, Lam TTY
    Transmission dynamics of the COVID-19 epidemics in England.
    Int J Infect Dis. 2020 Dec 22. pii: S1201-9712(20)32579.
    >> Share

  768. CAMPRUBI-FERRER D, Gaya A, Marcos MA, Marti-Soler H, et al
    Persistent replication of SARS-CoV-2 in a severely immunocompromised treated with several courses of remdesivir.
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32574.
    >> Share

  769. PAOLUCCI S, Cassaniti I, Novazzi F, Fiorina L, et al
    EBV DNA increase in COVID-19 patients with impaired Lymphocyte subpopulation count.
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32575.
    >> Share

  770. RAIMONDI A, Poma G, Piralla A, Meroni V, et al
    Looking for fever in Covid-19 nursing home residents: a false friend?
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32576.
    >> Share

  771. AL-MAHRUQI S, Al-Wahaibi A, Khan AL, Al-Jardani A, et al
    Molecular epidemiology of COVID-19 in Oman: a molecular and surveillance study for the early transmission of COVID-19 in the country.
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32573.
    >> Share

  772. JARVA H, Lappalainen M, Luomala O, Jokela P, et al
    Laboratory-based surveillance of COVID-19 in the Greater Helsinki area, Finland, February-June 2020.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32561.
    >> Share

  773. CEVALLOS-VALDIVIEZO H, Vergara-Montesdeoca A, Zambrano-Zambrano G
    Measuring the impact of the COVID-19 outbreak in Ecuador using preliminary estimates of excess mortality, March 17-October 22, 2020.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32567.
    >> Share

  774. WANG Y, Cao Z, Zeng DD, Zhang Q, et al
    The collective wisdom in the COVID-19 research: comparison and synthesis of epidemiological parameter estimates in preprints and peer-reviewed articles.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32563.
    >> Share

  775. HUH K, Ji W, Kang M, Hong J, et al
    Association of prescribed medications with the risk of COVID-19 infection and severity among adults in South Korea.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32565.
    >> Share

  776. CHEN B, Jiang C, Han B, Guan C, et al
    High prevalence of occult thrombosis in mild/moderate COVID-19.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32566.
    >> Share

  777. KOSANOVIC D, Yaroshetskiy AI, Tsareva NA, Merzhoeva ZM, et al
    Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32568.
    >> Share

  778. HWANG SE, Chang JH, Bumjo O, Heo J, et al
    Possible Aerosol Transmission of COVID-19 Associated with an Outbreak in an Apartment in Seoul, South Korea, 2020.
    Int J Infect Dis. 2020 Dec 17. pii: S1201-9712(20)32558.
    >> Share

  779. LI Y, Shi K, Qi F, Yu Z, et al
    Thalidomide Combined with Short-term Low-Dose Glucocorticoid Therapy for the Treatment of Severe COVID-19: A Case-Series Study.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32546.
    >> Share

  780. FISHER MJ, Raymundo LAM, Monteforte M, Taub EM, et al
    Tocilizumab in the Treatment of Critical COVID-19 Pneumonia: A Retrospective Cohort Study of Mechanically Ventilated Patients.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32544.
    >> Share

  781. FURUSE Y
    Genomic Sequencing Effort for SARS-CoV-2 by Country during the Pandemic.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32557.
    >> Share

  782. LIU J, Li K, Cheng L, Jingjin S, et al
    A high-throughput drug screening strategy against Conroviruses.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32556.
    >> Share

  783. RANDREMANANA R, Lazoumar RH, Tejiokem MC, Manirakiza A, et al
    Institut Pasteur international network's efforts to guide the control measure against Coronavirus Disease 2019 (COVID-19) epidemic among health care workers in Africa.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32553.
    >> Share

  784. CHUN JY, Baek G, Kim Y
    Corrigendum to "Transmission onset distribution of COVID-19" [Int. J. Infect. Dis. 99(October) (2020) 403-407].
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32501.
    >> Share

  785. DELEERS M, Breiman A, Daubie V, Maggetto C, et al
    Covid-19 and blood groups: ABO antibody levels may also matter.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32549.
    >> Share

  786. NI M, Xu H, Luo J, Liu W, et al
    Simultaneous detection and differentiation of SARS-CoV-2, influenza A virus and influenza B virus by one-step quadruplex real-time RT-PCR in patients with clinical manifestations.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32550.
    >> Share

  787. KOWALSKA JD, Kase K, Vassilenko A, Harxhi A, et al
    The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease - a report from Central and Eastern Europe.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32548.
    >> Share

  788. SAXENA S, Khurana A, B S, Sardana K, et al
    Severe Type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32547.
    >> Share

  789. RALLI M, Morrone A, Arcangeli A, Ercoli L, et al
    Asymptomatic patients as a source of transmission of COVID-19 in homeless shelters.
    Int J Infect Dis. 2020 Dec 12. pii: S1201-9712(20)32555.
    >> Share

  790. CELOTTO S, Veronese N, Barbagallo M, Ometto F, et al
    An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of hydroxychloroquine and chloroquine therapy.
    Int J Infect Dis. 2020 Dec 11. pii: S1201-9712(20)32541.
    >> Share

  791. BAO Y, Ling Y, Chen YY, Tian D, et al
    Dynamic Anti-Spike Protein Antibody Profiles in COVID-19 Patients.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32537.
    >> Share

  792. HU P, Ma M, Jing Q, Ma Y, et al
    Retrospective study identifies infection related risk factors in close contacts during COVID-19 epidemic.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32534.
    >> Share

  793. OLIYNYK OV, Rorat M, Barg W
    Oxygen metabolism markers as predictors of mortality in severe COVID-19.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32535.
    >> Share

  794. NILSSON AC, Holm DK, Justesen US, Gorm-Jensen T, et al
    Comparison of six commercially available SARS-CoV-2 antibody assays - choice of assay depends on intended use.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32540.
    >> Share

  795. LINSCHOTEN M, Nab L, van der Horst ICC, Tieleman R, et al
    Response to "Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients".
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32529.
    >> Share

  796. KITTEL M, Muth M, Zahn I, Roth P, et al
    Clinical evaluation of commercial automated SARS-CoV-2 immunoassays.
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32526.
    >> Share

  797. LAMMERS AJJ, Brohet RM, Theunissen REP, Koster C, et al
    Response to correspondence concerning: "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients".
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32531.
    >> Share

  798. VERHEIJEN S, van Luin M, Bruggemann RJ, de Mast Q, et al
    More gastro-intestinal adverse events in non-ICU hospitalized COVID-19 patients treated with chloroquine versus hydroxychloroquine.
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32533.
    >> Share

  799. SIKKENS JJ, Collard D, Peters EJG
    Comparison of hospital treatment strategy or of actually received treatment with hydroxychloroquine in COVID-19?
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32530.
    >> Share

  800. TARTERET P, Strazzulla A, Rouyer M, Gore C, et al
    Clinical features and medical care factors associated with mortality in French nursing homes during COVID-19 outbreak.
    Int J Infect Dis. 2020 Dec 7. pii: S1201-9712(20)32527.
    >> Share

  801. JARYNOWSKI A, Wojta-Kempa M
    Exploring the link between risk perception in Internet media and COVID-19 prevalence in Europe.
    Int J Infect Dis. 2020 Dec 5. pii: S1201-9712(20)32525.
    >> Share

  802. ALSHARIDAH S, Ayed M, Ameen RM, Alhuraish F, et al
    COVID-19 Convalescent Plasma Treatment of Moderate and Severe Cases of SARS-CoV-2 Infection: A Multicenter Interventional Study.
    Int J Infect Dis. 2020 Dec 4. pii: S1201-9712(20)32513.
    >> Share

  803. GUPTA M, Mohanta SS, Rao A, Parameswaran GG, et al
    Transmission dynamics of the COVID-19 epidemic in India and modelling optimal lockdown exit strategies.
    Int J Infect Dis. 2020 Dec 3. pii: S1201-9712(20)32522.
    >> Share

  804. LUDWIG M, Jacob J, Basedow F, Andersohn F, et al
    Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany.
    Int J Infect Dis. 2020 Dec 3. pii: S1201-9712(20)32520.
    >> Share

  805. AHMED S, Karim MM, Ross AG, Hossain MS, et al
    A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
    Int J Infect Dis. 2020 Dec 2. pii: S1201-9712(20)32506.
    >> Share

  806. TORRES B, Alcubilla P, Gonzalez-Cordon A, Inciarte A, et al
    Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome.
    Int J Infect Dis. 2020 Dec 2. pii: S1201-9712(20)32523.
    >> Share

  807. ZHANG M, Du L, Faleti OD, Huang J, et al
    Higher pharyngeal epithelial gene expression of Angiotensin-Converting Enzyme-2 in upper respiratory infection patients.
    Int J Infect Dis. 2020 Dec 2. pii: S1201-9712(20)32512.
    >> Share

  808. MILLER FD, La Croix S, Brown T, Ramsey LT, et al
    Unique pattern of COVID-19 infection in the State of Hawai'i.
    Int J Infect Dis. 2020 Dec 1. pii: S1201-9712(20)32517.
    >> Share

  809. MALAGON-ROJAS J, Parra E, Mercado M
    Letter to the editor on "Asymptomatic infection by SARS 2 coronavirus: Invisible but invincible" by Nikolai et al. 2020.
    Int J Infect Dis. 2020;101:391-392.
    >> Share

  810. LANGER-GOULD A
    Editorial Response to Drs. Simone and Mancusi.
    Int J Infect Dis. 2020;101:367.
    >> Share

    November 2020
  811. VELAVAN TP, Meyer CG
    COVID-19: A PCR-defined pandemic.
    Int J Infect Dis. 2020 Nov 30. pii: S1201-9712(20)32504.
    >> Share

  812. VITA S, Di Bari V, Corpolongo A, Goletti D, et al
    Down Syndrome patients with COVID-19 pneumonia: a high-risk category for unfavourable outcome.
    Int J Infect Dis. 2020 Nov 30. pii: S1201-9712(20)32503.
    >> Share

  813. MOTAYO BO, Oluwasemowo OO, Olusola BA, Akinduti PA, et al
    Evolution and genetic diversity of SARSCoV-2 in Africa using whole genome sequences.
    Int J Infect Dis. 2020 Nov 28. pii: S1201-9712(20)32505.
    >> Share

  814. SAHA J, Chouhan P
    Lockdown and unlock for COVID-19 and its impact on residential mobility in India: an analysis of the COVID-19 Community Mobility Reports, 2020.
    Int J Infect Dis. 2020 Nov 27. pii: S1201-9712(20)32502.